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Zusammenfassung 
 
In der medizinischen Diagnostik sind Röntgenstrahlen die am häufigsten verwendete Strahlenart und 
sie werden zunehmend auch bei schwangeren Frauen angewendet. Eine genaue Einschätzung des 
Gesundheitsrisikos für den sich entwickelnden Embryo ist daher notwendig. Da es ethisch nicht 
vertretbar ist, Strahleneffekte und deren Mechanismen im menschlichen Embryo zu untersuchen, wird 
ein geeignetes Modellsystem benötigt. Pluripotente, humane embryonale Stammzellen (hESCs) 
können fast unbegrenzt vermehrt und in alle Zellen des menschlichen Körpers differenziert werden 
und stellen somit ein vielseitiges in-vitro-Modell dar. Effekte verschiedener Noxen, wie beispielsweise 
ionisierende Strahlung (IR) oder Medikamente, auf die frühe menschliche Entwicklung sowie deren 
molekulare Mechanismen können mithilfe von hESCs untersucht werden. Das Herz ist das erste 
funktionelle Organ, deshalb ist seine korrekte Bildung die Voraussetzung für alle sich nachfolgend 
entwickelnden Organe, die mit Sauerstoff und Nährstoffen versorgt werden müssen. Der Einfluss einer 
pränatalen Strahlenexposition auf die kardiale Entwicklung wurde bisher nur in wenigen Studien 
untersucht. Diese zeigten, dass die kardiale Entwicklung muriner ESCs beeinträchtigt ist. 
In der vorliegenden Dissertation wurde der Einfluss einer Röntgenstrahlenexposition auf die kardiale 
Differenzierungsfähigkeit von hESCs untersucht. Die Differenzierung wurde eine Woche nach 
Bestrahlung initiiert. Sowohl Gen- und Proteinexpression verschiedener Marker als auch die 
Funktionalität der schlagenden kardialen Cluster wurden über 15 Tage hinweg untersucht. Dabei 
wurde eine dosisabhängige Abnahme der kardialen Genexpression beobachtet: Während 0,1 Gy einen 
geringen Effekt auf die Expression von NKX2.5, TNNT2, MYH6/7 und MLC2a/v hatte, war nach 
Bestrahlung mit 1 Gy eine deutliche Reduktion zu sehen. Diese war durch eine 2 Gy-Bestrahlung noch 
deutlicher und bereits bei einem Marker des kardialen Mesoderms (MESP1) sichtbar. Außerdem 
wurde in den Kardiomyozyten, die aus den 2 Gy-bestrahlten hESCs hervorgingen, kein MLC2v-
Protein detektiert, welches ein früher Marker der ventrikulären Spezifizierung und wichtig für die 
kardiale Kontraktion ist. Im Vergleich zu den Kontrollen zeigten diese Zellen des Weiteren geänderte 
Schlagraten und eine niedrigere Antwort auf Isoproterenol, ein Agonist der β-Adrenorezeptoren. 
Untersuchungen der molekularen Signalwege weisen darauf hin, dass diese Effekte durch ein 
beeinträchtigtes non-canonical-WNT-signaling und gp130-vermitteltes signaling bedingt werden.  
Da pluripotente Zellen nur vorübergehend während der frühen Schwangerschaft existieren, ist es 
statistisch wahrscheinlicher, dass eine Strahlenexposition zu einem späteren Zeitpunkt stattfindet. Um 
den Einfluss von IR auf differenzierende kardiale Kulturen zu untersuchen, wurden diese an 
bestimmten Zeitpunkten mit 1 Gy bestrahlt. Erste Experimente zeigten keine Änderungen auf 
molekularer und funktioneller Ebene.  
Diese Studie zeigte, dass hohe Dosen (2 Gy) einen deutlich negativen Effekt auf die kardiale 
Differenzierung von hESCs haben und auch die niedrigste getestete Dosis (0,1 Gy) zu dysregulierter 
kardialer Genexpression führt. Dies weist darauf hin, dass sich auch eine Dosis von 0,1 Gy, die 
   
V 
 
Schwellendosis für Missbildungen und geistige Retardierung, schädlich auf den frühen Embryo 
auswirken könnte, da Entwicklungsprozesse nach einem strikten zeitlichen Muster ablaufen und selbst 
kleinste Änderungen in den Signalwegen die normale Entwicklung in vivo stören. Allerdings muss 
beachtet werden, dass die gemessene Dosis am Uterus bei den meisten einmaligen diagnostischen 
Untersuchungen deutlich geringer ist als 0,1 Gy. 
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Abstract  
 
X-rays are the most commonly used radiation type in medical diagnostics and their application is 
increasing also in pregnant women. Therefore, a detailed health risk assessment for the developing 
embryo is needed. Since it is ethically not feasible to investigate radiation effects and their 
mechanisms directly in human embryos, a suitable model is needed. Pluripotent human embryonic 
stem cells (hESC) can be propagated almost infinitely and differentiated into all cells of the body, 
representing a versatile in vitro model system. Effects of various noxae, like ionizing radiation (IR) or 
newly designed drugs, on early human development and the underlying molecular mechanisms can be 
investigated using hESCs. Since the heart is the first functional organ, its normal formation is a 
prerequisite for the subsequently developing organs that need to be supplied with oxygen and 
nutrients. However, studies addressing the cardiac development upon prenatal IR exposure are scarce 
and based on murine ESCs suggesting that cardiac differentiation is impaired.  
The present study investigated the impact of X-ray exposure of hESCs on their cardiac differentiation 
capability. Differentiation was initiated seven days after exposure. Marker gene and protein expression 
as well as functionality of the beating cardiac clusters were investigated up to 15 days. A dose-
dependent decrease of cardiac gene expression was detected: whereas 0.1 Gy had a mild effect on 
several cardiac marker genes (e.g. NKX2.5, TNNT2, MYH6/7, MLC2a/v), their expression was 
markedly reduced following the 1 Gy exposure. Upon 2 Gy, this decrease was even more pronounced 
and already visible at the stage of cardiac mesoderm formation (MESP1). In addition, in cardiac 
clusters derived from 2 Gy-irradiated hESCs, MLC2v protein, an early ventricular marker, which is 
important for cardiac contraction, was not detected. Furthermore, their beat rates differed from those 
of controls and a lower response to isoproterenol, an agonist of β-adrenergic receptors, was observed. 
Molecular signaling pathway analyses suggest that these effects are linked to impaired non-canonical 
WNT signaling as well as gp130-mediated signaling. 
Since pluripotency occurs only transiently in the first days of the blastocyst stage, it is statistically 
more likely that a prenatal exposure occurs at a later developmental stage. To investigate the impact of 
IR on the developing cardiac cultures, they were irradiated with 1 Gy at specific stages of 
differentiation. First experiments did not reveal molecular or functional alterations.  
In conclusion, this study showed that a high X-ray dose (2 Gy) has a marked negative impact on 
cardiac differentiation of hESCs, but also the lowest dose tested (0.1 Gy) led to dysregulated cardiac 
gene expression. Thus, based on these results, even 0.1 Gy, which is the general threshold dose for 
malformations and mental retardation, might be harmful to the early embryo since developmental 
processes have a strict temporal pattern and even small alterations in the signaling pathways may 
hamper normal development in vivo. However, it has to be taken into account that the measured uterus 
dose of most single diagnostic procedures is much lower than 0.1 Gy.  
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1 Introduction 
 
In the past years, the application of X-rays for medical diagnoses is increasing also in pregnant 
patients: From 1997 to 2006, there was a 121 % increase of imaging tests using ionizing radiation (IR) 
in pregnant women and, for the use of computer tomography (CT) scans, a 25 % increase per year was 
observed (Chen et al., 2008). The risk of the developing embryo is estimated based on epidemiological 
studies of atomic bomb survivors (Lee et al., 1999; Schull and Otake, 1999; Tatsukawa et al., 2008) or 
upon nuclear catastrophes (Hatch et al., 2017; Lie et al., 2017) and on animal model studies (Kimler 
and Norton, 1988; Pampfer and Streffer, 1988; Saito et al., 2015). However, there are difficulties with 
the extrapolation of these data. In addition, it is ethically infeasible to investigate the molecular 
mechanisms of IR-induced effects in human embryos. For this reason, human embryonic stem cells 
(hESCs) that can be differentiated in vitro into all cells of the three germ layers were selected in the 
present study as a suitable model system to investigate the impact of IR on early development. The 
development of the heart begins around week 2 - 3 post conception, around week 4 the heart starts to 
beat and around week 7 it is fully septated and connected to the aorta (Brade et al., 2013). Since it is 
the first functional organ, all subsequently arising tissues and organs depend on its correct formation. 
Hence, the presented study investigates the effects of IR on the cardiac differentiation capability of 
hESCs. 
 
1.1 Physics of ionizing radiation and its effect during prenatal exposure 
Organisms on earth are constantly exposed to IR via natural or man-made sources. IR comprises all 
radiation types that have enough energy to eject single electrons of atoms and thereby, ionize them, 
which means that a positively charged ion and at least one secondary electron are generated (Hall and 
Giaccia, 2006). The dose (D), which is received by a target is defined as the energy (E) in Joule (J) 
absorbed per mass unit (m) in kg and is measured in Gray (Gy):  
 
Dose = 
𝐸
𝑚
 ; [D] = 
𝐽
𝑘𝑔
 = Gy 
 
Today, there is a growing number of radiological examinations in pregnant patients. X-rays are the 
most commonly used radiation type in medicine. They are photons that are indirectly ionizing, which 
means that the generated secondary electrons ionize other molecules in the irradiated target, leading to 
the production of free radicals (Hall and Giaccia, 2006). In biological systems, water molecules are the 
most likely target, generating hydroxyl radicals, which can lead to DNA damage being the most severe 
radiation-induced cellular damage type. 
An in utero exposure to IR can have severe consequences, comprising non-cancer health effects as 
well as mutagenic and carcinogenic effects. The risks of an in utero exposure depend on the stage of 
development and the dose (De Santis et al., 2007). The pregnancy can be divided into three periods: 
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the preimplantation period (day 0 - 10 post conception), organogenesis (day 10 - week 8) and the fetal 
period (3
rd
 - 9
th
 month). As summarized by Williams and Fletcher (2010), an exposure above 0.1 Gy 
within the first ten days of pregnancy is associated with an increased risk of implantation failure. 
However, embryos that survive in this stage are unlikely to have non-cancer health effects. Upon an 
exposure during organogenesis or early fetal development (until week 15), mental retardation and 
growth restriction are the most common malformations. Whereas non-cancer health effects are not 
associated with an exposure to doses below 0.05 Gy at any stage of development, there is an increased 
risk of childhood malignancies like leukemia at any prenatal stage of development and dose (Williams 
and Fletcher, 2010).  
The pregnancy might not always be known at the time when radiological examinations or a radiation 
therapy are necessary and some examinations cannot be avoided even if the pregnancy is known. The 
risk of the developing embryo is evaluated by physicians according to the recommendations of the 
Deutsche Gesellschaft für medizinische Physik: 100 mSv, which corresponds to 100 mGy in the case 
of X-rays, is reported to be the threshold dose for malformations and mental retardation. In 90 % of all 
cases of X-ray diagnostics, the uterus dose is lower than 20 mSv and there is no increased risk for the 
embryo. If the exposure occurred within the first ten days of the pregnancy (i.e. pre-implantation 
phase), no further dose calculation is needed since the embryo will either survive without damage or it 
will fail to implant with a threshold uterus dose of 100 mSv. However, if the exposure occurs after this 
phase, the dose should be calculated by the physician. If it is below 100 mSv, the patient will be 
informed, but an abortion is not recommended. Above 100 mSv, the increased risk of malformations 
or mental retardation should be considered by the patient. Nonetheless, the physician will only 
recommend an abortion if the uterus dose is higher than 200 mSv (DGMP- und DRG-Bericht, 2002). 
Still, there is a need for further investigations of the exact risks and the underlying molecular 
mechanisms leading to radiation-induced health effects. Since it is ethically unjustifiable and 
infeasible, this cannot be studied directly in human embryos. The only available human in vivo data 
derive from epidemiological studies of atomic bomb survivors. However, since many other factors like 
nutrition, mental stress of the mother or uptake of medicine, drugs or chemicals by the mother (Barker, 
1999; Mone et al., 2004) influence embryonic development, these data are difficult to extrapolate. 
Furthermore, mechanistic studies are not possible in vivo. Therefore, a suitable in vitro model is 
needed. With the generation of embryonic stem cell (ESCs) lines, such a model was established 
allowing the investigation of the impact of various noxae, like IR or drugs, on embryogenesis. 
 
1.2 Stem cells 
ESCs are pluripotent, which means that they have the potential to proliferate almost indefinitely (self-
renewal) and give rise to all cells of the three germ layers (endo-, meso- and ectoderm). In 1981, the 
first successful establishment of murine ESCs (mESC) line was achieved by two labs (Evans and 
Kaufman, 1981; Martin, 1981). Human ESCs (hESC) lines, including the H9 line used in the present 
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study, were first established by Thomson et al. (1998). ESCs are obtained from blastocysts. These are 
embryos that consist of the outer cell layer, called trophoblast, giving rise to the extraembryonic 
tissues, and of the inner cell mass, which will give rise to the organism and is the source of ESCs. 
However, besides species-dependent differences, murine and human ESCs represent slightly different 
developmental stages of the blastocyst. hESCs are termed “primed”, whereas mESCs are termed 
“naïve” (Morgani et al., 2017; Nichols and Smith, 2009). 
Since hESCs derive from human embryos, ethical concerns arise and their use in research is strictly 
limited. In Germany, the legal basis for their scientific use is provided by the Embryonenschutzgesetz 
and the Stammzellgesetz. Research on hESCs must be of high basic or medical interest and it must be 
justified that it cannot be performed with another model system.  
hESCs are a versatile tool for research and medicine. For example, they can be used to study the 
earliest steps of embryo- and cardiogenesis. Furthermore, hESC-derived cardiomyocytes (CM) are a 
promising tool for the preclinical screening of newly developed drugs for cardiotoxic and pro-
arrythmic effects as well as for regenerative medicine and to treat cardiovascular diseases like 
myocardial infarction or heart failure. For example, it was recently reported by Liu et al. (2018) that 
hESC-derived CM were able to implant successfully into infarcted hearts of macaques, thereby 
restoring cardiac function without the onset of arrhythmias, which were observed in a previous study 
(Chong et al., 2014). The first human trial using hESC-derived cardiac progenitor cells for treating 
severe heart failure was initiated in 2013 (ESCORT, Menasché et al., 2015) and first results of this 
study are promising (Menasché et al., 2017). 
 
1.2.1 Maintenance and markers of pluripotency in hESCs 
Pluripotency is maintained by a complex signaling network, comprising TGF-β, FGF, NOTCH and 
WNT signaling. The strict regulation and interplay of all these pathways leads to the inhibition of 
differentiation on the one hand and on the other hand to the expression of the core transcriptional 
regulatory circuit, which is made up of OCT4, SOX2 and NANOG that ensure maintenance of 
pluripotency and self-renewal (Yeo and Ng, 2013). These three transcription factors are used as a 
quality-control of hESCs. OCT4, encoded by the POU5F1 gene, is a homeodomain protein and plays 
a critical role in the establishment and maintenance of pluripotency. Precise regulation of OCT4 is 
crucial since even small alterations in its amount lead to differentiation (Niwa et al., 2000; Wang et al., 
2012). Its synergistic action with NANOG, another homeodomain protein, and SOX2 ((Sex 
determining region Y)-box 2), is well described (see Yeo and Ng, 2013 for further references). These 
three transcription factors co-occupy more than 300 target genes (Boyer et al., 2005). Among others 
they target their own genes in autoregulatory loops, but they also repress differentiation genes.  
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1.2.2 Unique features of human ESCs 
Apart from pluripotency and infinite self-renewal, ESCs possess additional unique characteristics that 
distinguish them from differentiated cells and enable them to protect themselves more efficiently 
against DNA damage to maintain genomic integrity of the stem cell-pool and give rise to normal 
progeny cells (reviewed by Nagaria et al., 2013). hESCs have a lower mutation frequency compared to 
differentiated cells (Cervantes et al., 2002) and are able to undergo cell death in a facilitated manner as 
a means to avoid mutations. For this reason, they express, for example, constitutively active BAX, 
which is rapidly and p53-dependently translocated to the mitochondria upon apoptotic stimuli to 
induce cytochrome c release and caspase activation leading to apoptosis (Dumitru et al., 2012). In 
contrast, BAX is present in an inactive conformation in somatic cells and must be activated prior to its 
translocation. Therefore, the induction of apoptosis is faster in hESCs. 
hESCs originate from the blastocyst that developed under low oxygen tensions in the oviduct and 
uterus (Fischer and Bavister, 1993) and they proliferate well under hypoxic conditions (Ezashi et al., 
2005) using anaerobic glycolysis (Varum et al., 2011). Consistent with this, hESCs have a low number 
of mitochondria with a rather immature phenotype. Thus, a lower amount of reactive oxygen species 
(ROS) can be found and, in addition, more antioxidant enzymes are produced (Saretzki et al., 2004). 
However, during differentiation both, mitochondria number and maturity level, increase (Cho et al., 
2006; John et al., 2005).  
The cell cycle of hESCs is much shorter than the one of proliferating somatic cells. This is attributable 
to a short G1 phase (Becker et al., 2006), during which hESCs are the most sensitive to differentiation 
signals (Pauklin and Vallier, 2013; Sela et al., 2012). 
 
1.2.3 Response of ESCs to IR – state of the art 
The response of murine and human ESCs to IR was intensively investigated in the past years using X- 
or γ-rays. Upon exposure, the first visible reaction of the ESCs is the formation of holes within and a 
decreased number and size of the colonies. This is attributable to apoptosis and cell death (Momcilovic 
et al., 2009; Rebuzzini et al., 2012; Wilson et al., 2010). In line with this, a dose- and radiation quality-
dependent reduction in the clonogenic survival was described (Luft et al., 2014; Rebuzzini et al., 
2012).  
The most severe IR-induced cellular damages are those of the DNA and efficient mechanisms exist to 
allow their repair. A common DNA damage sensor in somatic cells, namely ATM, was found to be 
activated also in ESCs. It phosphorylates and thereby stabilizes the transducer proteins p53 and CHK2 
(Momcilovic et al., 2009). Subsequently, cell cycle arrest occurs to ensure the repair of the IR-induced 
damage. ESCs are capable of inducing a transient dose-dependent cell cycle arrest at G2/M phase, but 
not at G1-phase (Filion et al., 2009; Luft et al., 2014; Rebuzzini et al., 2012). The higher the dose, the 
longer is the duration of the G2/M arrest. For mESCs, Rebuzzini and colleagues found it to last 48 h 
upon a 5 Gy γ-ray exposure, yet in another study, the arrest was no longer visible at 6 h after 2 Gy X-
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rays (Luft et al., 2014). Momcilovic et al. (2009) reported that hESCs returned to cell cycle 16 h after 
exposure to 2 Gy γ-rays and that the G2/M arrest requires ATM, but is independent of p21. Even 
though p21 mRNA is increased upon DNA damage induction (Becker et al., 2007; Filion et al., 2009; 
Sokolov et al., 2015; Wilson et al., 2010), ESCs fail to accumulate p21 protein (Filion et al., 2009; 
Dolezalova et al., 2012). This is due to hESC-specific microRNAs that prevent its protein expression 
(Dolezalova et al., 2012), which might explain the lack of a G1-cell cycle-arrest in hESCs. 
DNA double strand breaks (DSBs) are the most critical damage to cells and are repaired via two major 
pathways: The main repair pathway of DSBs in mammalian somatic cells is the Non-Homologous 
End-Joining (NHEJ) that operates in all cell cycle phases and is considered to be error-prone 
(Pannunzio et al., 2018). Homologous Recombination (HR) relies on the presence of sister chromatids 
as repair template and therefore, only takes place during late S and G2 phase and is error-free (San 
Filippo et al., 2008). mESCs predominantly repair DSBs via HR (Tichy et al., 2010). In contrast, 
hESCs utilize both, HR as well as a high-fidelity NHEJ and levels of proteins involved in both 
pathways are elevated enabling a more efficient repair compared to differentiated cells (Adams et al., 
2010a, 2010b; Fan et al., 2011).  
Whole-genome expression analyses by Sokolov et al. (2015) revealed that exposure to low dose IR 
leads to a time- and hESC line-dependent genomic response. At an early time point after exposure (2 h 
upon 0.05 Gy), only expression of CDKN1A (encoding p21) was increased in all tested cell lines, 
whereas all other differentially expressed genes were cell line-dependent. In contrast, a high dose 
(1 Gy) led to enhanced expression of multiple genes involved in p53 signaling, apoptosis and cell 
cycle arrest. At a late time point (16 h) after 1 Gy exposure, 16 genes were consistently upregulated, 
which are involved anti-apoptotic signaling and DNA damage/stress response, whereas upon low dose, 
no transcriptomic effects were detected. 
Furthermore, it is well described that ESCs that survive an IR exposure maintain pluripotency even 
upon a relatively high 4 Gy-dose as evidenced by the expression of pluripotency markers (Luft et al., 
2014; Momcilovic et al., 2009; Rebuzzini et al., 2012) and by teratoma formation in immuno-
compromised mice (Wilson et al., 2010). In addition, differentiation markers were not found to be 
increased upon IR exposure (Sokolov et al., 2010,Wilson et al., 2010).  
 
1.3 The mammalian heart – development, electrophysiology and radioresponse  
The heart is the first functional organ during human development and its correct formation is crucial 
for the supply of the embryo with oxygen and nutrients. In vitro studies addressing the influence of 
noxae, like IR, on heart development contribute to the risk assessment for an in utero exposure.  
 
1.3.1 Development of the mammalian heart 
With the appearance of the primitive streak in the epiblast of the blastula, gastrulation starts and 
results in the formation of endo-, ecto- and mesoderm. The mesoderm, from which the mammalian 
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heart is formed, is further subdivided into the paraxial, intermediate and lateral plate mesoderm. Cells 
of the latter give rise to the first and second heart fields (SHF). The cells of the first heart fields (FHF) 
are lateral on both sides of the primitive streak and migrate to fuse at the midline forming the so called 
cardiac crescent (Fig. 1 A). This structure will give rise to the linear heart tube that starts to beat 
subsequently (week 4 of human development). The heart tube expands by cell proliferation and 
recruitment of additional cells originating from the SHF. It consists of multipotent cardiac progenitor 
cells with increased proliferation and delayed differentiation compared to the FHF cells. Subsequent 
looping and extensive growth give rise to the fetal heart, which displays well-defined chambers at day 
32 of human development (Brade et al., 2013). Whereas the SHF cells give rise to the outflow tract, 
inflow region/atria and right ventricle, FHF cells contribute partially to the atrial myocardium and 
exclusively to the left ventricle (reviewed by Brade et al., 2013; Cyganek et al., 2013; Kelly et al., 
2014; Fig. 1 B). Around week 7 of human gestation, the heart is fully septated and connected to the 
vascular system. 
 
 
Fig. 1: Contribution of the first and second heart field to the developing mammalian heart. A) The cells of 
the FHF make up the cardiac crescent (pink). Whereas the cells of the FHF differentiate already at the crescent 
stage forming the linear heart tube, the cells of the SHF (blue) show delayed differentiation that starts upon their 
gradual migration into the linear heart tube. B) Contribution of the FHF and SHF cells to the components of the 
heart. Figure modified and reprinted from Kelly (2012) with permission from Elsevier. 
 
All these developmental steps rely on the complex promoting and inhibiting signaling of multiple 
pathways. The tissues adjacent to the mesoderm, like endoderm, neurectoderm and the Node, secrete 
the respective signaling molecules. As described by Burridge et al. (2012) mesoderm induction starts 
with NODAL signaling in the epiblast, thereby maintaining BMP4 in the adjacent extraembryonic 
ectoderm. Secretion of BMP4 leads to the induction of canonical WNT signaling in the proximal 
epiblast via WNT3 (Burridge et al., 2012). Thereby, Brachyury and Eomesodermin are expressed 
(early primitive streak) and lead to the expression of the transcription factor MESP1, which is a key 
regulator of the differentiation of mesodermal cells into cardiac progenitor cells (Bondue et al., 2008). 
For this differentiation step, BMP, FGF, NODAL and Sonic Hedgehog (SHH) signaling are crucial 
(Wagner and Siddiqui, 2007). MESP1 directly or indirectly promotes expression of key cardiovascular 
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transcription factors like HAND2, NKX2.5 and GATA4 finally leading to the expression of cardiac 
structural proteins like MYH6, MYH7, TNNT2 and MLC2v (reviewed by Bondue and Blanpain, 
2010).  
Canonical WNT signaling plays a biphasic role during cardiac development: whereas it is crucial for 
mesoderm formation, it is inhibitory for cardiac specification after the formation of cardiac mesoderm 
(Naito et al., 2006). Therefore, canonical WNT signaling is rapidly downregulated by antagonists like 
Dickkopf-1 (DKK1) secreted by the surrounding tissues, but also MESP1 was shown to upregulate 
DKK1 expression (David et al., 2008). In addition, WNT11 was shown to inhibit canonical WNT 
signaling by caspase-mediated destabilization of β-catenin (Abdul-Ghani et al., 2011). In contrast to 
canonical WNT signaling, the non-canonical signaling mediated by WNT11 plays a supportive role in 
the cardiac specification phase (Mazzotta et al., 2016; Pandur et al., 2002a). Furthermore, BMP 
signaling is required for CM differentiation and the Serum Response Factor (SRF) regulates 
expression of microRNAs (miR-1 and miR-133) that lead to the withdrawal of the differentiating cells 
from the cell cycle (Evans et al., 2010). 
During the heart tube stage, fundamental patterning events occur that determine chamber and non-
chamber myocardium. The chamber specification results from the expression of transcriptional 
regulators, like IRX4, HAND1 and ANF (encoded by NPPA), and connexin proteins. In addition, T-
box transcription factors play crucial roles at this step: Whereas TBX5 and TBX20 promote chamber 
specification, TBX2 and TBX3 inhibit them to maintain non-chamber properties (reviewed by 
Dunwoodie, 2007). A gradient expression of TBX5 is realized by retinoic acid signaling leading to its 
expression in atria and the left ventricle. It acts synergistically with NKX2.5 and GATA4 to activate 
expression of NPPA and GJA5 (encoding connexin 40 expressed in fast-conducting tissue and together 
with connexin 43 in the working myocardium of the atria and ventricles). TBX3 suppresses chamber 
specification and leads to the expression of the pacemaker channel HCN4 in the cells that will give 
rise to the sinoatrial node (SAN). 
Another crucial signaling pathway throughout the development of the heart is the NOTCH signaling. 
It is activated upon cell-cell contact via the interaction of a receptor (NOTCH1-4) with a 
transmembrane ligand (Jagged and Delta proteins; reviewed by Kopan, 2012) and contributes to 
cardiogenesis from as early as the cardiac crescent stage to cardiac valve development (reviewed by 
De la Pompa and Epstein, 2012). It was shown to interact with the non-canonical WNT signaling 
(Koyanagi et al., 2007). Conflicting data exist suggesting either a promoting or an inhibiting effect of 
NOTCH signaling on cardiogenesis (e.g. Jang et al., 2008; Koyanagi et al., 2007; Rones et al., 2000). 
However, there is evidence that active NOTCH signaling promotes proliferation of cardiac precursors 
by blocking differentiation (Cyganek et al., 2013; Schroeder et al., 2006). 
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1.3.2 Cardiac electrophysiology and excitation-contraction coupling 
All tissues of the human body need to be supplied with oxygen and nutrients. This is realized by the 
contraction of the heart, which pumps the blood through the vessels and relies on electrical signals, i.e. 
ion currents. Cardiac action potentials (AP) arise from changes in the transmembrane electrical 
potential in CMs. The morphology of a typical cardiac AP is depicted in Fig. 2, however, depending 
on the localization within the heart, the morphology of the APs varies due to distinct ion channels and 
currents (electrical heterogeneity; Liu et al., 2016). For example, only the atria possess the ultra-rapid 
outward K
+
 current generated by Kv1.5 (encoded by KCNA5), acetylcholine-activated K
+
 current, T-
type Ca
2+
 current and Ca
2+
-activated K
+
 current.  
 
 
Fig. 2: Morphology of a typical ventricular action potential. The cardiac AP can be divided into five phases: 
0 = upstroke, 1 = early repolarization, 2 = plateau, 3 = late repolarization, 4 = diastolic phase. Figure modified 
from Beeler and Reuter (1977).  
 
As reviewed by Liu et al. (2016) the AP consists of five phases (Fig. 2). Phase 4 is the diastolic phase 
representing the resting membrane potential. During this phase, K
+
 channel activity dominates via the 
inward rectifier current (IK1). Phase 0 is initiated by depolarization arising from electric coupling 
between adjacent CMs via gap junctions and is characterized by rapid influx of Na
+
 ions via voltage-
gated Na
+
 channels (Nav). The membrane potential moves toward the equilibrium potential of Na
+
 
(around + 50 mV). However, the maximal voltage reached in ventricular and atrial CM is between 
+ 20 and 40 mV. Upon closing of the Nav-channels, depolarizing Ca
2+
 currents (especially L-type Ca
2+
 
currents) as well as repolarizing currents via Kv channels, Ca
2+
-activated Cl
-
 channels and the Na
+
/Ca
2+
 
exchanger (NCX) emerge in phase 1. The NCX operates in the reverse mode during this phase moving 
three Na
+
 ions outward for one Ca
2+
 ion inward. The elevated intracellular level of Ca
2+
 leads to the 
opening of the RyR2 channels of the sarcoplasmic reticulum (SR), thereby inducing Ca
2+
 release from 
the SR (Fig. 3 A) leading to the contraction of the CM via excitation-contraction coupling (Fig. 3 B). 
CM are made up of sarcomeres consisting of thin (actin) and thick (myosin) filaments. Actin filaments 
are surrounded by tropomyosin, which is associated with troponin T, C and I. Myosin molecules 
consist of a head, neck and tail domain. Upon the drastically increased intracellular Ca
2+
 
concentration, Ca
2+
 ions bind to troponin C leading to a conformational change of the tropomyosin. 
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Thereby actin is exposed and the myosin head can bind. Via ATP hydrolysis, the myosin head moves 
and the actin slides across the myosin filament, thereby shortening the muscle (power stroke; 
contraction). Subsequently, the myosin detaches from the actin. The contraction lasts until the end of 
phase 2 (plateau). For cardiac relaxation, the intracellular Ca
2+
 concentration is decreased via the SR 
Ca
2+
-ATPase (SERCA), which pumps the Ca
2+
 back into the SR, and the NCX as well as Ca
2+
-
ATPases located in the CM membrane to move the Ca
2+
 out of the cell (Fig. 3 B). 
Phase 3 is initiated when the net outward K
+
 current exceeds the depolarizing currents ICa,L and INCX. In 
this phase, IKr is the most important current.  
 
 
Fig. 3: Mechanism of muscle contraction and relaxation. A) Ca
2+
 ions enter the cell and mediate the Ca
2+
-
induced Ca
2+
-release from the SR leading to muscle contraction. During muscle relaxation, intracellular Ca
2+
 
levels are actively decreased via SERCA2a, NCX and Ca
2+
 ATPases. Figure modified from Shenoy and 
Rockman (2011). B) The cardiac muscle consists of actin and myosin filaments. Actin is surrounded by 
tropomyosin, which is associated to the troponin complex consisting of troponin T, C and I (1). When Ca
2+
 ions 
bind to troponin C (2), the tropomyosin exposes actin, to which the myosin heads can bind (3). Using ATP, the 
myosin head pulls at the actin, which slides across the myosin filament leading to muscle shortening (4, power 
stroke; contraction). Figure modified according to Alberts et al. (2009) and Seidman and Seidman (2001). 
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The cardiac AP is initially generated in the SAN CM driving the depolarization of the adjacent CM via 
gap junctions consisting of connexin proteins. The AP of the SAN is different to those of the atria and 
ventricles. There is no stable resting potential in phase 4, instead the SAN AP is characterized by a 
slow diastolic depolarization phase (Baruscotti et al., 2005). When the maximum diastolic potential 
(MDP) is reached (between -70 and -55 mV), slow spontaneous depolarization occurs. At around  
-50 mV, the funny current (If, also called “pacemaker current”) is provided by the Hyperpolarization-
activated cyclic nucleotide-gated (HCN) channels. HCN4 is the major isoform in the SAN (Stieber et 
al., 2003). The opening potential of these channels depends on the intracellular cAMP-level, which is 
controlled by β-adrenergic receptors. HCN channels conduct Na+ and K+ and their main function is the 
generation of the sinus rhythm via the SAN AP. 
 
1.3.3 The development of the heart can be recapitulated in vitro using ESCs 
Using specific protocols, hESCs can be differentiated into all cells of the three germ layers. To 
generate hESC-derived CM, the distinct stages of the heart development are recapitulated in vitro by 
regulating the same signaling pathways as in vivo and can be monitored via marker expression on the 
mRNA and protein level (Boheler et al., 2002; Fig. 4 A). Cardiac differentiation protocols start with 
the development of mesodermal cells via the enhancement of canonical WNT signaling. Many 
protocols additionally regulate BMP and Activin A signaling for the initial step. According to Singh et 
al. (2012), Activin A leads to the expression of NANOG via SMAD2/3 when PI3K/AKT activity is 
high and canonical WNT signaling is absent. However, when PI3K/AKT signaling is low and 
canonical WNT signaling is active, Activin A/SMAD2/3 signaling leads to the expression 
differentiation-associated genes, like the mesendodermal markers Eomesodermin (EOMES) and 
MIXL1 (Singh et al., 2012). 
Mesodermal cells are Brachyury (T) positive leading to the expression of MESP1 when cardiac 
mesoderm is formed. They represent the early primitive streak and gastrulation stage. Subsequently, 
WNT signaling is downregulated by addition of specific inhibitors. Depending on the inhibitor used, 
either canonical and non-canonical or only canonical WNT signaling can be blocked (Chen et al., 
2009; Huang et al., 2009). Based on detailed WNT signaling studies in hESCs, Mazzotta et al. (2016) 
proposed a model for the contributions of the multiple WNT pathways at distinct stages of cardiac 
differentiation (Fig. 4 B). 
Canonical WNT signaling is mediated via accumulation of β-catenin (reviewed by MacDonald et al., 
2009). In the absence of WNT ligands, β-catenin is phosphorylated by the destruction complex, which 
includes the protein kinases GSK3 and CK1α. Subsequently, β-catenin is ubiquitylated and thus 
targeted for degradation. Thereby, target gene expression is repressed (MacDonald et al., 2009). In 
contrast, when WNT proteins bind to the Frizzled (FZD) family receptors associated with LRP5/6, the 
subsequent recruitment of GSK3 and CK1α leads to the phosphorylation of LRP5/6. The destruction 
complex is disrupted, allowing β-catenin to accumulate in the cytoplasm and translocate into the 
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nucleus where it associates with LEF/TCF. The transcriptional repressors are removed from the target 
genes and their transcription takes place (MacDonald et al., 2009). This signaling pathway promotes 
differentiation of hESCs in a concentration-dependent manner (Blauwkamp et al., 2012; Davidson et 
al., 2012). In contrast, it is not required for pluripotency maintenance (Singh et al., 2012) and it was 
shown to be repressed by OCT4 (Davidson et al., 2012) and SOX2 (Zhou et al., 2016) in hESCs.  
Non-canonical WNT signaling pathways do not involve β-catenin. An overview of their molecular 
mechanisms is given by Semenov et al. (2007). WNT/JNK signaling operates via the ROR2 receptor 
and the activation of PI3K and JNK leading to target gene expression. According to Mazzotta et al. 
(2016) it is required for the formation of MESP1-positive cardiogenic mesoderm. WNT/Ca
2+
 signaling 
is promoted via the FZD4/6 receptor (Mazzotta et al., 2016) and leads to an increase of intracellular 
Ca
2+
 levels. Both non-canonical pathways antagonize the canonical WNT/β-catenin signaling and are 
required for gastrulation (Semenov et al., 2007). In addition, WNT/Ca
2+
 signaling is required for CM 
development from cardiac progenitors (Mazzotta et al., 2016). 
 
 
Fig. 4: Cardiac differentiation. A) Each stage of the in vivo heart development can be recapitulated in vitro 
with the directed cardiac differentiation of hESCs. B) Canonical and non-canonical WNT signaling during 
cardiac differentiation. Figure modified according to Mazzotta et al. (2016). 
 
Following MESP1 expression, cardiac precursor genes, like NKX2.5, GATA4 and TBX5 are expressed. 
The developing CM assemble in cardiac clusters, which start to beat spontaneously around day 8 of 
differentiation. This is accompanied by the expression of cardiac markers like cardiac troponin T 
(cTNT, encoded by TNNT2) and cardiac specific myosins (e.g. MYH6/7, MLC2a). Depending on the 
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protocol, atrial (NPPA) or ventricular (IRX4, MLC2v) markers may emerge with ongoing 
differentiation. There is an increasing number of protocols that allow the generation of the specific 
cardiac cell types, e.g. atrial differentiation is promoted by retinoic acid and ventricular differentiation 
is enhanced by blocking retinoic acid signaling (Zhang et al., 2011). However, in the present study, 
heterogeneous cardiac cultures containing all cardiac cell types as well as non-cardiac cells are desired 
to mimic the heart as an organ consisting of various cell types as close as possible.  
 
A major problem of hESC-derived CM is, however, their immature morphological and functional 
properties (Yang et al., 2014). In recent years, several approaches that aim at the maturation of the in 
vitro-generated CM were developed. Kolanowski et al. (2017) provided a comprehensive overview of 
the current knowledge on CM maturation. Without specific maturation protocols, hESC-derived CM 
are more similar to early fetal than to adult ones.  
 
1.3.4 Effect of ionizing radiation on the heart and cardiac development – state of the art 
It is known that radiation exposure of the heart to high doses leads to cardiac injury. Acute or early 
cardiac effects are rare, since the heart is known to respond late, i.e. years or decades after the 
exposure (Boerma et al., 2016). For example, upon radiotherapy of breast cancer, there is an increased 
risk of mortality due to cardiovascular diseases especially if the women were treated for left-sided 
breast cancer (Bouillon et al., 2011). Recent reviews on radiation-induced cardiovascular disease are 
provided by Boerma et al. (2016) and Puukila et al. (2017). Typical cardiac effects comprise chronic 
inflammation, oxidative stress, damage to microvasculature, ischemia, accelerated atherosclerosis and 
fibrosis, but also injuries to the cardiac valves are described. Epidemiological studies of atomic bomb 
survivors who were exposed during childhood or adolescence showed an elevated risk for heart 
diseases like hypertension, stroke and myocardial infarction also at doses below 1 Gy (Shimizu et al., 
2010; Yamada et al., 2004). In addition, increased blood levels of inflammatory cytokines were found 
(Hayashi et al., 2003).  
Animal studies addressing cardiac effects of radiotherapy found that cardiac injury rather depends on 
the dose per fraction than on the total dose. In rat and mouse hearts, common IR-induced effects were 
damages to the endothelium, fibrosis and hypertension (Baker et al., 2009; Boerma et al., 2004). In 
addition, elevated levels of connexin 43 (Cx43) mRNA and protein were detected leading to increased 
intercellular communication probably to enhance transmission of radiation-induced signals (Amino et 
al., 2006 and references within). Total body irradiation of postnatal and adult mice leads to an altered 
cardiac transcriptome and proteome and 0.5 Gy γ-rays or more resulted in reduced expression of 
cytoskeletal proteins (e.g. actin, myosin) indicating degenerating heart structure (Bakshi et al., 2013; 
Coleman et al., 2015). Cardioprotective mechanisms were elevated before clinical symptoms in 
cardiac function were observed according to Coleman et al. (2015). Similarly, Seemann et al. (2012) 
reported that cardiac function of murine hearts irradiated with high X-ray doses remained normal 
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despite vascular changes suggesting compensatory mechanisms, which, however, failed after 
prolonged time. In contrast, whole body proton (0.5 Gy) and iron ion (0.15 Gy) irradiation of adult 
mice led to impaired cardiac function up to 10 months post irradiation with increased cardiac fibrosis, 
altered cardiac calcium homeostasis and activation of cardiac hypertrophy signaling (Yan et al., 2014). 
Primary chicken CM irradiated with 0.5 to 7 Gy X-rays showed dose-dependently increased beat rates, 
however, upon 0.5 and 1 Gy these alterations were minor (Frieß et al., 2015). When such CM were 
irradiated with heavy ions, a high functional robustness as well as a low apoptotic rate was observed 
(Heselich et al., 2018). Only high doses (2 and 7 Gy) of titanium ions were shown to impair their beat 
rates. 
 
Data on the impact of a radiation exposure on the fetal heart are scarce. Atomic bomb survivors that 
were exposed in utero showed a dose-dependent cancer incidence and the most prominent non-cancer 
effects were microcephaly and mental retardation (Kodama et al., 1996). No significant association 
between an in utero exposure and non-fatal cardiovascular diseases (stroke and myocardial infarction) 
or hypertension has been reported (Tatsukawa et al., 2008).  
Although ESC maintain their pluripotent potential upon IR exposure, whole-genome transcription 
studies indicated that gene expression of several signaling pathways is altered (Sokolov et al., 2015, 
2011; Wilson et al., 2010) and thus, their differentiation capability may be affected. For example, a 
downregulation of ACVR1B and ACVR2A expression in hESCs exposed to 1 Gy X-rays was reported 
(Luft et al., 2017). Since these genes encode activin receptors, not only differentiation into definitive 
endoderm as reported by the authors, but also cardiac differentiation could be impaired (compare 
section 1.3.3).  
Whether specifically cardiac differentiation is affected by an IR exposure was analyzed in only three 
studies up to date. Two of them used mESCs and the same differentiation technique demonstrating an 
impaired cardiac differentiation (Helm et al., 2016; Rebuzzini et al., 2013). Whereas Rebuzzini and 
coworkers found an increased expression of several cardiac marker genes (Nkx2.5, Gata4, Alpk3 and 
Tnnc1) upon an exposure to 5 Gy γ-rays, Helm and colleagues described a rather decreased expression 
(Tnnt2, Myh7, Myl4, Hcn4) with C-ions being more effective than X-rays. Additionally, decreased 
beat rates and contraction force were described and correlated to a decreased density of Cx43 
(Rebuzzini et al., 2013). Both studies show that cardiac differentiation of mESCs is affected by IR 
exposure, which may markedly impair the complex signaling networks and correct development of the 
developing fetus. Still, the effect of an IR exposure on human cardiac development was only 
investigated in one study up to date using human induced pluripotent stem cells (Baljinnyam et al., 
2017). However, the culture conditions are artificial and the observed effects are questionable. For 
example, ROCK inhibitor is used for a prolonged time to enhance cell attachment and, furthermore, 
low dose α-particles were used leading to a very small fraction of cells that are hit by a particle (i.e. 
only 3 % of the cell population). 
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1.4 Objective 
The medical use of X-rays for diagnostics in pregnant patients is increasing, therefore, a detailed risk 
assessment for the developing embryo is needed. Even though many studies showed that ESCs 
maintain pluripotency upon IR exposure, they also revealed that several signaling pathways are 
affected as indicated by altered gene expressions (see section 1.2.3). These alterations could lead to an 
impaired subsequent differentiation and organ formation. During human development, the heart is the 
first functional organ and it meets the metabolic demands of the developing embryo. For this reason, 
its correct development is crucial to ensure growth and health of the fetus. Although it is known that 
there is an association between IR exposure of the heart and an increased risk for cardiovascular 
diseases, the impact of an in utero exposure on the early heart and its further development is not clear 
yet. Studies directly addressing the impact of an IR exposure on cardiac development are scarce. Two 
of these reported altered gene expressions in cardiac cultures derived from mESCs and impaired CM 
functionality (Helm et al., 2016; Rebuzzini et al., 2013). Since these results are difficult to extrapolate 
to human heart development due to species-dependent differences, the objective of this study is to 
characterize the influence of an X-ray exposure on cardiac differentiation capability of hESCs. Upon 
optimization of the cardiac differentiation conditions, the effect of multiple X-ray doses was 
investigated via marker gene and protein expression as well as functional assessments of the beating 
CM. For this, videos were recorded and beat rates as well as beat variability were analyzed with a 
recently developed software called cardiac Beat Rate Analyzer (cBRA; Nitsch et al., 2018). With the 
same method, the functionality of β-adrenergic receptors and HCN channels was tested using 
isoproterenol and ivabradine. Furthermore, pathway analyses based on qRT-PCR arrays and literature 
research were performed to shed light on possible mechanisms underlying IR-induced effects.  
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2 Material and Methods 
 
In the following section, methods applied in this study are described. Kits, media, supplements and 
chemicals are listed separately in the appendix (App. Tables 1 - 3) including their manufacturers and 
ordering numbers. Furthermore, manufacturers of devices and softwares are also listed in the appendix 
(App. Tables 4 and 5).  
 
2.1 Cell lines and culture conditions 
Mouse embryonic fibroblasts (PMEF-NL) were obtained from Millipore, Germany, in passage 3 and 
used as feeder layer for the hESC line H9. The work with hESCs was approved by the Robert-Koch-
Institute (registry number: 1710-79-1-4-69) in concordance with the German stem cell law (§ 11 
StZG). Two hESC lines obtained from the WiCell Research Institute, Wisconsin were used: the 
wildtype cell line WA09 (H9) and the transgenic cell line H9-hTnnTZ-pGZ-D2 (cTNT-H9). The 
wildtype H9 cells were delivered at passage 26 and co-cultured with mitotically inactivated mouse 
embryonic fibroblast (MEF) feeder cells in H9-medium (see Table 1) and supplemented with 10 ng/ml 
FGF2. For experiments, H9 cells from passage 37 to 74 were used.  
 
Table 1: Composition of H9-medium. 
Component Final concentration 
Knockout DMEM  
+ Knockout Serum Replacer 20 % 
+ L-Glutamine 1 mM 
+ Non-Essential Amino Acids 1x  
+ β-Mercaptoethanol 100 µM 
+ Penicillin/Streptomycin 50 U/ml Pen., 50 µg/ml Strep. 
 
The transgenic cTNT-H9 cell line was generated at the University of Wisconsin by Dr. Timothy 
Kamp’s lab (Wrighton et al., 2014). In these cells, GFP is under the control of the cardiac troponin T-
promoter making this cell line suitable to monitor cardiac differentiation. They were obtained at 
passage 37 and cultured feeder-independently on Laminin-521-coated petri dishes in mTeSR1-
medium (see Table 2). For experiments, cTNT-H9 cells from passage 57 to 82 were used. All hESCs 
were cultured at 37 °C with ambient oxygen and 5 % CO2.  
 
Table 2: Composition of mTeSR1-medium. 
Component Final concentration 
mTeSR1 Basal Medium  
+ 5x mTeSR1-supplement 1 x 
+ Penicillin/Streptomycin 50 U/ml Pen., 50 µg/ml Strep. 
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2.1.1 Mouse Embryonic Fibroblasts (MEFs) expansion and storage 
PMEF-NL were obtained from Millipore in passage 3 and propagated until passage 6, in which they 
were mitotically inactivated to be used as feeder cells. Thawed MEFs were transferred into MEF-
medium (DMEM + 9 % FCS + 1 % Penicillin/Streptomycin) and centrifuged for 5 min at 300 x g. The 
pellet was solved and 1.5 - 2.5 x 10
6
 cells were seeded per T75 culture flask in a total of 15 ml MEF-
medium. Before reaching confluency, MEFs were passaged as follows: medium was aspirated, cells 
were washed with PBS
+/+
 and incubated with trypsin for 5 min at 37 °C. After detachment, they were 
resuspended in MEF-medium, transferred into a 50 ml reaction tube and centrifuged at 200 x g for 
5 min. The pellet was resuspended and 2.5 x 10
6
 cells were seeded per T75 culture flask in a total 
volume of 15 ml MEF-medium. 
At passage 6, MEFs were mitotically inactivated. For this purpose, they were harvested as described 
before, collected in a T25 culture flask on ice and exposed to 60 Gy X-rays. Afterwards, the cells were 
transferred into a 50 ml reaction tube and centrifuged. The pellet was solved in freezing medium 
(90 % FCS + 10 % DMSO). Aliquots of either 3 or 6 x 10
6 
cells in 1.8 ml were frozen over night at  
-80 °C and then transferred to liquid nitrogen. 
 
2.1.2 Preparation of MEF conditioned medium 
MEF conditioned medium was used for the immediate culture of H9 cells upon thawing. For its 
preparation, 4.5 x 10
6
 MEFs were seeded per T75 flask and cultured in H9-medium including 
10 ng/ml FGF2. The medium was changed after 24 h and subsequently, the conditioned medium was 
collected for four days, filtered through a 20 µm pore filter and stored at -20 °C. 
 
2.1.3 H9 cells – thawing  
H9 cells were cultured upon delivery and frozen at passage 32 in freezing medium and liquid nitrogen.  
Since H9 cells were grown on mitotically inactivated MEFs, petri dishes needed to be prepared one 
day before the H9 cells were thawed. For this purpose, Ø 6 cm petri dishes (21 cm2) were coated with 
0.1 % gelatin in PBS by incubating for at least 1 h at 37 °C. The gelatin solution was aspirated, 2 ml 
MEF-medium were added and the dishes were returned to the incubator. Mitotically inactivated MEFs 
(see section 2.1.1) were thawed in the water bath until only a small piece of frozen cells remained. The 
cells were transferred to 10 ml cold MEF-medium and centrifuged for 5 min at 200 x g. The pellet was 
resuspended in prewarmed (37 °C) MEF-medium, cells were counted with an automatic cell counter 
and seeded at a density of 0.24 x 10
5
 cells/cm
2
. On the next day, the medium was aspirated, cells were 
washed with PBS
+/+
 and incubated for at least 1 h in conditioned medium, which was supplied with 
10 ng/ml FGF2. Then the feeder layer was ready for use.  
H9 cells were thawed in a water bath until only a small frozen piece remained, transferred into cold 
H9-medium and centrifuged for 8 min at 300 x g. The pellet was carefully resuspended in conditioned 
medium without disrupting small cell clumps and seeded onto the MEF feeder cells. After 24 h, 
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medium was switched to H9-medium including 10 ng/ml FGF2. Subsequently, medium change was 
performed every day. 
 
2.1.4 Manual passage of the H9 cells 
For routine culture, H9 cells were passaged manually once a week. For this, petri dishes containing 
mitotically inactivated MEF were prepared as described before. One hour before passage of the H9 
cells, the MEF containing petri dishes were washed with PBS
+/+
 and H9-medium was added. To avoid 
daily medium change, 8 µl/ml (= 10 ng/ml) StemBeads® FGF2 were added to the H9-medium 
supplying the cells with a steady release of FGF2 for four days.   
Colonies with undifferentiated morphology were chosen for propagation (Fig. 5 A, red arrow), while 
differentiated ones (Fig. 5 B, blue arrows) were excluded. The selected colonies were dissected with a 
scalpel (Fig. 5 C) at a microscope with 100 x magnification under an open laminar flow cabinet 
(ENVAIReco) and transferred to the prepared petri dishes. After four days, daily medium change with 
H9-medium including 10 ng/ml non-beads-coupled FGF2 was performed. 
 
Fig. 5: Manual passage of H9 cells. A) Undifferentiated H9 colonies (red arrow) grown on MEF feeder cells 
(yellow arrow) were chosen for passage based on their morphology, whereas B) colonies containing 
differentiated cells (blue arrows) were excluded. C) Dissection of selected colonies into squares with a scalpel, 
followed by their transfer into a new petri dish, which was preseeded with MEF feeders. After 7 days in culture, 
manual passage was repeated. Scale bars: 100 µm. 
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2.1.5 Passage of H9 cells with the non-enzymatic passaging reagent ReleSRTM 
For radiation experiments, H9 cells were passaged with ReleSR
TM
, a non-enzymatic passaging reagent 
from STEMCELL Technologies that preferentially detaches pluripotent stem cells from the culture 
dish. Thereby, the yield of H9 cells was enhanced and the effort of manual passaging was reduced. 
Briefly, the medium was aspirated and cells were rinsed with 200 µl ReleSR
TM
. It was aspirated 
completely and the cells were incubated for 2 - 4 min at 37 °C. After 2 min, detachment of the 
pluripotent cells was controlled at the microscope. To stop the reaction, the cells were rinsed with H9-
medium and subsequently split 1:3. Cells were exposed four days after passaging (section 2.4). 
 
2.1.6 H9-hTnnTZ-pGZ-D2 human embryonic stem cells (cTNT-H9) 
cTNT-H9 cells were thawed in a 37 °C water bath until only a small piece of frozen cells remained, 
transferred into H9-medium and centrifuged for 5 min at 200 x g. The pellet was resuspended carefully 
in mTeSR1-medium (see Table 2) and distributed to four Laminin-coated wells (10 µg/ml Laminin-
521) of a Nunc
TM
 6-well-plate (Thermo Fisher Scientific). Medium change was performed every day. 
Upon propagation, cTNT-H9 cells were frozen at passage 54 in freezing medium over night at  
-80 °C and then transferred to liquid nitrogen. 
cTNT-H9 cells were subcultured using the ReleSR
TM
-method (compare section 2.1.5) to ensure that 
only undifferentiated cells were passaged (Fig. 6 A, red arrow). After aspiration of the reagent, cells 
were incubated for 2 min at 37 °C. When the pluripotent cells detached (Fig. 6 B, red arrows), the 
reaction was stopped by addition of prewarmed mTeSR1-medium. Split ratios between 1:3 and 1:15 
were used depending on how many cells detached. Medium was changed every day. Upon recovery 
from thawing, the cells were cultured routinely on 5 µg/ml Laminin-521. 
 
 
Fig. 6: Passage of cTNT-H9 cells using the ReleSR
TM
-method. A) During culture in mTeSR1-medium on 
Laminin-521-coated petri dishes, some cTNT-H9 cells started to differentiate spontaneously (yellow arrows). To 
ensure that only undifferentiated, pluripotent cells (red arrow) were passaged, the ReleSR
TM
-method was 
applied. B) ReleSR
TM
 only detaches pluripotent stem cells (bright cells, red arrows), whereas differentiated cells 
(yellow arrows) stay attached to the surface of the culture dish. Scale bars: 100 µm. 
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2.2 Cytogenetic analyses of cTNT-H9 cells 
Since genomic stability of hESCs is influenced by the method of passaging, ReleSR
TM
-passaged 
cTNT-H9 cells were analyzed via multicolor Fluorescence in situ hybridization (mFISH) for 
chromosomal aberrations at various passages. To accumulate the cells in metaphase, 0.1 µg/ml 
colcemide (stock concentration: 10 µg/ml) was added 2 h before harvest. Subsequently, the medium 
was collected in a 15 ml reaction tube and cells were incubated with ReleSR
TM
 for 2 min at 37 °C. 
Detaching cells were collected and transferred to the reaction tube. The cell suspension was repeatedly 
pipetted up and down to obtain single cells and subsequently, centrifuged for 5 min at 200 x g. The 
supernatant was discarded and the pellet was solved in prewarmed 0.075 M KCl (ad 10 ml) and 
incubated for 8 min at 37 °C followed by 8 min centrifugation at 200 x g. Fixative solution 
(methanol:acetic acid 3:1) was added to the pellet dropwise (ad 10 ml). The suspension was 
centrifuged for 10 min at 300 x g. Afterwards, the pellet was resuspended in 10 ml fixative, incubated 
for 30 min at room temperature (RT) and again centrifuged (10 min, 300 x g). The supernatant was 
removed, the pellet was resuspended in fixative (200 - 400 µl) and subsequently, the cell suspension 
was dropped onto wet microscope slides. The spreads were air dried and finally hybridized with the 
24xCyte Human Multicolor FISH Probe Kit according to the manufacturer’s protocol. Images of the 
metaphase spreads were taken with an Axio Imager Z2 microscope and Metafer 4 software. Their 
analysis was performed with the ISIS Software.  
 
2.3 Cardiac differentiation of hESCs 
Two protocols for directed cardiac differentiation were compared: the GiWi (GSK3-inhibitor, WNT-
inhibitor)-protocol published by Lian et al. (2013a; Lian protocol) and an enhanced protocol published 
by Kadari et al. (2015; Kadari protocol). For both, the hESCs were seeded on Matrigel® at high 
density and the same basal medium is used. However, according to Kadari et al., ascorbic acid is 
additionally added and thus, present during the entire differentiation process (see Table 3). The factors 
used and the exact time table of the two protocols is depicted in Fig. 7. For their comparison, H9 cells 
were seeded four days before initiation of differentiation (d-4) on Matrigel®-coated (42 µg/cm²) 6-
well-plates (Sarstedt), Ø 6cm or Ø 3.5 cm (8.8 cm²) NuncTM-petri dishes at a density of 0.3 x 106 
cells/cm². For the first 24 h, 5 µM Y-27632 ROCK inhibitor was added to prevent apoptosis and help 
single cells to attach. Until initiation of differentiation (d0), the cells were cultured in mTeSR1-
medium, which was changed every day. 
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Table 3: Composition of the basal medium for cardiac differentiation depending on the protocol. 
Lian protocol  Kadari protocol  
Component Final concentration Component Final concentration 
RPMI-1640 (w. stable glutamine) RPMI-1640 (w. stable glutamine) 
+ B-27 minus insulin 1 x + B-27 minus insulin 1 x 
+ Penicillin/Streptomycin 0.5 % + Ascorbic acid 50 µg/ml 
  + Penicillin/Streptomycin 0.5 % 
 
 
Fig. 7: Directed cardiac differentiation protocols. CHIR99021 is used by Lian et al. (2013a) to initiate cardiac 
differentiation and IWP2 from day 3 to day 5 to promote cardiac specification. In contrast, Kadari et al. (2015) 
additionally used BMP4 in the first 24 h and addition of CHIR99021 was prolonged. Instead of IWP2, XAV939 
was used from day 3 to day 7. Starting from day 7, medium was changed every two to three days. 
 
2.4 X-ray irradiation 
X-ray exposure was carried out at an Isovolt DS1 X-ray tube with 250 kV and 16 mA at RT. The dose 
was measured with a SN4-dosimeter, the dose rate was approximately 1 Gy/min. cTNT-H9 cells were 
irradiated with either 0.1, 1 or 2 Gy and three days later, they were seeded on Geltrex® (0.12 -
 0.18 mg/ml protein)-coated culture plates. Controls were sham-irradiated. Seven days after 
irradiation, cardiac differentiation was initiated (Fig. 8 a).  
In another setup, differentiating CM derived from cTNT-H9 cells were irradiated at day 5 or 8 of 
differentiation with 1 Gy (Fig. 8 b).  
 
 
Fig. 8: Setup of X-ray irradiation experiments. (a) Pluripotent cTNT-H9 cells were irradiated with 0.1, 1 or 
2 Gy X-rays. Three days later, they were seeded on Geltrex®-coated culture plates and seven days after 
irradiation (day 0), cardiac differentiation according to Kadari et al. (2015) was initiated. (b) In another setup, 
differentiating cTNT-H9 cells were irradiated at day 5 or at day 8 with 1 Gy X-rays. 
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2.5 Quantification of cell death upon X-ray irradiation 
To compare the apoptotic rate of wildtype H9 and cTNT-H9 cells, both cell lines were passaged with 
the ReleSR
TM
-method and cultured feeder-free on Laminin-coated Ø 3.5 cm NuncTM-petri dishes in 
mTeSR1-medium. Using the CellEvent
TM
 Caspase-3/7 Green Flow Cytometry Assay Kit, living 
(instead of fixed) cells are required. For this reason, cells were irradiated with 1 Gy after 4, 5 and 
6 days of culture on Laminin-coated dishes to quantify the apoptotic and necrotic fraction at all time 
points (72, 48 and 24 h after irradiation, respectively) at the same day (see Fig. 9). Medium was 
changed directly after exposure and then every 24 h. 
 
 
Fig. 9: Quantification of the apoptotic and necrotic fraction at several time points after X-ray exposure of 
hESCs. Cells were seeded on Laminin and after 4, 5 or 6 days, they were irradiated with 1 Gy X-rays. At day 7 
after passage, they were harvested for FACS analysis to determine the apoptotic and necrotic fraction at the 
indicated time points.  
 
For cell harvest, the medium was passed through a 40 µm cell-strainer (Corning) and collected in a 
15 ml reaction tube for each sample. The cells were detached and singularized by incubation with 
Accutase® for 5 - 10 min at 37 °C. They were collected with cell scrapers and passed through the 
strainers into the 15 ml reaction tubes. Subsequently, the strainers were rinsed with cold PBS
+/+
, the 
cell suspensions were carefully mixed and cells were counted. The suspensions were centrifuged for 
5 min at 300 x g (RT). Pellets were resuspended and diluted in 2 % BSA in PBS
+/+
 to obtain cell 
suspensions with 1 x 10
6
 cells/ml. 1 ml of the samples was incubated with 1 µl CellEvent
TM
 Caspase-
3/7 Green Detection Reagent at 37 °C for 25 min to mark apoptotic cells. Subsequently, 1 µl of 1 mM 
SYTOX AADvanced was added for another 5 min to stain necrotic cells. For each cell line, an 
unstained control and controls for each dye were prepared. Fluorescence intensity was measured using 
a BD FACSCanto
TM
II flow cytometer with the BD FACSDiva™ v7.0 software and the 530/30 and 
670/LP filters for Caspase-3/7 Green Detection Reagent and SYTOX AADvanced dyes, respectively. 
 
2.6 qRT-PCR-based marker gene expression analyses  
RNA samples were taken at specific days of cardiac differentiation by lysing the cells with 700 µl 
QIAzol Lysis Reagent. They were stored at -80 °C until further processing. RNA was isolated from 
the cell lysates based on phenol-chloroform extraction and affinity chromatography with the RNeasy 
MiniKit according to the miRNeasy Mini Handbook from QIAGEN. For collecting the RNA from the 
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columns, they were centrifuged for 2 min at 8000 x g with 30 µl RNase-free water. Eluated samples 
were put on ice immediately and RNA concentrations were measured at a nanophotometer (Colibri, 
Titertek Berthold). Until further processing, RNA samples were stored at -80 °C.  
 
2.6.1 Markers of pluripotency and differentiation 
4 µg RNA were transcribed into cDNA using the RevertAid RT Kit according to the manufacturer’s 
protocol in a 40 µl approach. The reaction was performed in the PCR Thermal Cycler Peqstar. Upon 
cDNA synthesis, samples were diluted in an equal volume of nuclease-free water. For each target 
gene, triplicates of each sample were pipetted into a 96-well-plate (Sarstedt). For the housekeeping 
gene (18sRNA, as used by Luft et al., 2017), samples were diluted 1:100 in nuclease-free water. The 
plates were sealed, briefly centrifuged and placed into the StepOnePlus RT PCR System or 
QuantStudio3. The cycling program was: 15 min at 95 °C, followed by 45 cycles of 15 s at 95 °C, 20 s 
at 60 °C and 20 s at 72 °C. A melt curve cycle of 15 s at 95 °C, 60 s at 60 °C and 15 s at 95 °C 
completed each PCR run. The results were analyzed with the ABI StepOne Software v2.3 or with 
QuantStudio
TM
 Design & Analysis Software v1.4. For each target, the threshold was adjusted 
manually to match between experiments to be compared. Since the primer pairs used in these analyses 
are not equally efficient, the standard curve method was applied. RNA samples used for the generation 
of standard curves are listed in App. Table 6. mRNA levels were normalized to 18sRNA. To compare 
the mRNA expression of marker genes between the Lian and Kadari protocol, or between controls and 
irradiated samples, a second normalization was performed: All values were normalized to the highest 
expression level of each target achieved with the Lian protocol, or with control samples in case of 
irradiation experiments. Primers were produced by the company biomers.net (sequences are listed in 
App. Table 7) and solved in 1 x TE buffer upon arrival. They were used at a concentration of 1 µM.  
 
2.6.2 microRNA-1 
1 µg RNA was transcribed into cDNA using the miScript II RT Kit according to the manufacturer’s 
instructions. Afterwards, cDNA concentration was measured at the nanophotometer and the cDNA 
was diluted to 250 ng/µl in 100 µl with nuclease free water. miR-1-content of the samples was 
investigated in triplicates of the prepared cDNA. As a housekeeping gene, SNORD25-11 was used 
(see Luft et al., 2017). qRT-PCR was performed using the miScript SYBR Green PCR Kit and primers 
were obtained from QIAGEN (Hs_miR-1_2 and Hs_SNORD25_11 miScript Primer Assays). The 
following cycling program was used: 15 min at 95 °C, followed by 45 cycles of 15 s at 94 °C, 30 s at 
55 °C and 30 s at 70 °C. PCR analysis was completed with a melt curve cycle of 15 s at 95 °C, 60 s at 
60 °C and 15 s at 95 °C. Subsequently, the standard curve method was applied to determine the 
relative amount of miR-1. Values were normalized to SNORD25-11 and to the miR-1 level of controls 
at day 15 of differentiation. 
 
   
  - 23 - 
2.7 qRT-PCR-array based analyses of DNA Damage Response and Stem Cell Signaling 
cTNT-H9 cells were irradiated with 1 Gy X-rays and RNA samples were taken 1 h, 6 h, 24 h, and 7 d 
after exposure by lysing the cells with QIAzol Lysis Reagent. RNA isolation was performed as 
described in section 2.6. RNA was eluated with 25 µl RNase-free water. After RNA isolation, n = 6 
samples were pooled for each time point (2 µg of each sample). For subsequent cDNA-synthesis with 
the RT² First Strand Kit, 1 µg RNA was used. The cDNA synthesis was performed according to the 
manufacturer’s protocol in the Peqstar PCR Thermal Cycler. Afterwards, cDNA was diluted in equal 
volume of RNase-free water and stored at -20 °C until further analyses. According to the 
manufacturer’s protocol, cDNA and the RT² SYBR Green ROX qPCR Mastermix were mixed and 
diluted in nuclease-free water. Using a multichannel pipette (VWR), 25 µl of the mixes were pipetted 
into the wells of the Human Stem Cell Signaling PCR Array (PAHS-047ZA, QIAGEN) and the 
Human DNA Damage Signaling Pathway PCR Array (PAHS-029ZC, QIAGEN) plates. They were 
sealed, centrifuged and placed into the StepOnePlus RT PCR System. The following cycling program 
was used: 10 min at 95 °C, followed by 40 cycles of 15 s at 95 °C and 60 s at 60 °C. The PCR run was 
completed by a melt curve cycle with 15 s at 95 °C, 60 s at 60 °C and 15 s at 95 °C. Subsequent 
analyses were performed with the ABI StepOne Software v2.3 and the Data Analysis Center of 
www.qiagen.com using the ΔΔCT method. Both PCR arrays contained five housekeeping genes for 
normalization. However, not all of them were suited for normalization since their expression differed 
markedly between the samples. For the Stem Cell Signaling Array, GAPDH, HPRT1 and RPLP0 were 
selected for normalization due to very similar CT-values among all samples. For the DNA Damage 
Response Signaling Pathway Array, two normalization methods were chosen and compared with each 
other: in a first approach, B2M and HPRT1 were used for normalization. In a second approach, the 
genes NBN, FEN1, PPP1R15A, FANCA, H2AFX were chosen since their expression was comparable 
between all samples. 
 
2.8 Immunocytochemical analyses of pluripotency and differentiation markers 
For immunocytochemical analyses of proteins, cells were grown in petri dishes on Ø 12 mm round 
coverslips, which were either preseeded with MEF feeder cells (H9 cells, see section 2.1.3) or 
Laminin-coated (cTNT-H9 cells). Cells were fixed at several days to analyze for pluripotency markers 
(day 0), endothelial markers (day 5 and 8) and cardiac markers (day 8 and 15). Briefly, the medium 
was aspirated, cells were washed with PBS and fixed with 3.7 % formaldehyde (FA) for 15 min on 
ice. Subsequently, they were washed three times and stored at 4 °C in PBS until immunocytochemical 
staining. 
To permeabilize the cells, they were treated 30 min at RT with 0.5 % Triton X-100 diluted in 1 % 
BSA. Subsequently, unspecific binding sites were blocked by incubating with 1 % BSA for 30 min 
(RT). Then, the cells were incubated with the primary antibody diluted in 1 % BSA (antibodies and 
dilutions are listed in Table 4) over night at 4 °C in a humidifying chamber. Cells were washed and 
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subsequently incubated with the secondary antibody (diluted 1:400 in 1 % BSA, see Table 5) for 30 -
45 min at 37 °C in the dark. After another washing step, DNA was stained with Hoechst-33342 
(diluted 1:1000 in ultrapure water) for 4 min (dark, RT). Cells were washed once with PBS and two 
times with ultrapure water. Coverslips were mounted on slides (Carl Roth) with Fluorescent Mounting 
Medium, sealed with nail polish and stored at 4 °C until microscopy. A Leica DMI 4000B microscope 
was used to take Z-stack images and focus stackings of these were generated in ImageJ/Fiji. For 
intensity measurements, average intensity projections were used. 
 
Table 4: Primary antibodies for immunocytochemical analyses. 
Antigen Manufacturer  
ID 
Antibody raised in Dilution 
Alpha Actinin 
(sarcomeric) 
Sigma-Aldrich/Merck 
A7732 
mouse 1:1500  
ATM Millipore/Merck 
04-200 
rabbit 1:100 
Cardiac Troponin T Santa Cruz 
sc-20025 
mouse 1:400 
CD31 Abcam 
ab28364 
rabbit 1:25 
Connexin 43 (GJA1) Abcam 
ab11370 
rabbit 1:1000 
 
HCN4 Abcam 
ab66501 
rabbit 1:2000 
MLC2 Abcam 
ab79935 
rabbit 1:1500 
MYL7 Santa Cruz 
sc-365255 
mouse 1:400 
Nanog (Alexa Fluor® 
488 anti-human Nanog) 
BD Pharmingen 
560791 
mouse 1:10 
OCT-3/4 Santa Cruz  
sc-5279 
mouse 1:400 
p21 Calbiochem 
OP64 
mouse 1:100 
SOX2 Santa Cruz  
sc-17319 
goat 1:300 
vWF Sigma-Aldrich/Merck 
3520 
rabbit 1:500 
 
Table 5: Secondary antibodies. 
Antibody Manufacturer 
ID 
Reactivity Dilution 
Alexa Fluor® 488 Life technologies 
A11070 
goat-anti-rabbit 1:400 
Alexa Fluor® 488 Life technologies 
A11001 
goat-anti-mouse 1:400 
Alexa Fluor® 568 Life technologies 
A11036 
goat-anti-rabbit 1:400 
Alexa Fluor® 568 Life technologies 
A11004 
goat-anti-mouse 1:400 
Alexa Fluor® 594 Life technologies 
A11058 
donkey-anti-goat 1:400 
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The noise signal was generally high in all samples. However, using 4 % goat serum for blocking 
instead of 1 % BSA as well as fixing the cells for a shorter time (15 min) on ice instead of a prolonged 
time at RT did not reduce the unspecific signal. Nonetheless, specific signals could clearly be 
distinguished from noise. 
 
2.9 Video analyses of the beating hESC-derived cardiac clusters 
Spontaneous beating of the hESC-derived cardiac clusters was first observed between day 6 and 8 of 
differentiation. To evaluate the beating characteristics (beat rate and beat variability), the software 
cBRA (cardiac Beat Rate Analyzer) was developed (Nitsch et al., 2018). Videos were recorded at day 
8, 10 (or 11) and 15 of differentiation (for details see Nitsch et al., 2018). 
To analyze the presence and functionality of β-adrenoreceptors, two clusters for each condition were 
recorded before and after addition of 1 µM isoproterenol. 
Furthermore, presence and functionality of HCN4 channels were investigated with ivabradine. 
Therefore, the same clusters were recorded before and after addition of ivabradine. Increasing 
concentrations between 2 - 100 µM were added to the cultures derived from sham and 1 Gy-irradiated 
cTNT-H9 cells.  
 
2.10 Electrophysiological measurements of cTNT-H9-derived cardiomyocytes 
cTNT-H9-derived cardiac cultures at day 15 of differentiation were exemplarily measured in the 
whole-cell configuration of the current clamp technique in collaboration with the group of Prof. Dr. 
Gerhard Thiel at Technical University Darmstadt. The clusters were not dissociated into single cells 
since dissociation with trypsin or Accutase® was not successful. Therefore, current clamping was 
more difficult and only three CM, which were located at the edges of beating clusters, could be 
measured. Intra- and extracellular solutions were prepared according to Spencer et al. (2014). 4 GΩ 
capillaries were pulled and heated up for 15 min. Before measurement, 2 mM ATP was added to the 
intracellular solution, which was subsequently warmed in a 37 °C water bath. Culture medium was 
removed and replaced by the extracellular solution. Using an EPC-9 (Vers. C) Patch Clamp Amplifier 
(HEKA Elektronik), spontaneous AP were recorded with the I0-current at RT with the software 
PatchMaster v2x90 (HEKA Elektronik). The maximum diastolic potential and AP amplitudes were 
calculated and compared to literature values. 
 
2.11 Statistical analyses 
PCR data are presented in column scatter plots with the median line or as dose effect-curves showing 
the median of all experiments with the standard error of the median. Beat rates determined via video 
analyses in cBRA are presented in box plots with the median and the 25 % and 75 % quartiles for each 
experiment. All results are based on n ≥ 3 independent experiments if not denoted differently. 
Statistical significance was determined by Student’s t-test (* p < 0.5, ** p < 0.01, *** p < 0.001). 
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3 Results 
 
3.1 Characterization of the H9-derived cardiac cultures using two different protocols 
Two recent protocols for directed cardiac differentiation (Kadari et al., 2015; Lian et al., 2013a) were 
compared using the H9 cells in n = 6 independent experiments. Cells were seeded on Matrigel®-
coated plates (see section 2.3) and four days later (d0) their pluripotency was confirmed by 
immunocytochemical detection of OCT4, SOX2 and NANOG (Fig. 10). However, some cells were 
negative for these markers and had a different morphology hinting at spontaneous differentiation (not 
shown). Directed cardiac differentiation was performed as shown in Fig. 7. From day 1 to 3 massive 
cell death was observed microscopically independent of the culture protocol (not shown). 
Cardiac development was confirmed by the onset of spontaneous contraction of the clusters between 
day 6 and 8 of differentiation. However, the cluster morphology differed depending on the protocol: 
Whereas the clusters resulting from the Kadari protocol were round and compact, those derived from 
the Lian protocol were strand-like and developed a higher degree of interconnectedness until day 15 
(Nitsch et al., 2018). 
 
 
Fig. 10: Immunocytochemical staining of the core pluripotency transcription factors in H9 cells before 
initiation of cardiac differentiation. After four days of feeder-free culture on Matrigel®-coated coverslips, H9 
cells were fixed and stained for OCT4, SOX2 and NANOG. DNA was stained with Hoechst-33342. Scale bars: 
20 µm. 
 
3.1.1 qRT-PCR based analyses of stage-specific cardiac marker gene expression 
The cardiac cultures generated with the two protocols were compared based on qRT-PCR analyses of 
known marker genes of cardiac differentiation. Absolute gene expressions varied among experiments, 
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as shown in Fig. 11 - 13. However, the general trend was similar. After initiation of differentiation, 
expression of the pluripotency marker genes POU5F1 (encoding OCT4) and NANOG decreased with 
both protocols (Appendix (App.) Fig. 1 A, B).  
At day 1 and 2 of differentiation, expression of T (encoding Brachyury) and MESP1, which are 
markers for mesodermal and cardiac mesodermal cells (Saga et al., 2000; Showell et al., 2004), is 
upregulated, respectively, with both protocols (Fig. 11 A, B). Interestingly, MESP1 expression was 
induced simultaneously with T at day 1 using the Kadari protocol, whereas with the Lian protocol 
MESP1 was only upregulated at day 2. 
Following the downregulation of T and MESP1, cardiac progenitor markers like GATA4 and NKX2.5 
(Fig. 11 C, D) were upregulated at day 5. Since their expression varied markedly among the 
experiments, no clear difference between the two protocols could be observed. However, by trend, 
especially the expression of NKX2.5 was higher using the Kadari protocol. Expression of ISL1, 
another marker for cardiac progenitors, was by trend higher with the Kadari protocol until day 8 where 
it peaked for this protocol. In contrast, using the Lian protocol, its expression peaked at day 15 (App. 
Fig. 1 C). 
WNT11, a marker for non-canonical WNT signaling, was first detected at day 2. With the Lian 
protocol, its mRNA level peaked at day 15, however, with the Kadari protocol, it peaked already at 
day 8 and its expression remained high until day 15 (App. Fig. 1 D). 
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Fig. 11: qRT-PCR based analyses of early cardiac differentiation marker genes comparing two protocols. 
Pluripotent H9 cells (black) were differentiated according to the Lian (red, n = 6) and Kadari protocol (green, 
n = 6 until day 5, n = 4 at day 8 and 15). At multiple days during differentiation, expression of T (A), MESP1 
(B), GATA4 (C) and NKX2.5 (D) were investigated via qRT-PCR. Values were normalized to 18sRNA and the 
highest mRNA level of each target achieved with the Lian protocol. Student’s t-test was performed among 
experiments. * p < 0.05; black lines: median; d, day. 
 
Cardiac troponin T (cTNT) is essential for CM contraction (Sehnert et al., 2002, see section 1.3.2). It 
is encoded by the gene TNNT2 whose expression appeared at day 5 and increased until day 15 
(Fig. 12 A) independent of the protocol. However, its expression was higher in the cardiac cultures 
derived from the Kadari protocol. 
The pacemaker marker HCN4 was already expressed in undifferentiated cells (Fig. 12 B). Starting 
from day 8, its expression was elevated and peaked at day 15. With the Kadari protocol, HCN4 
expression was higher. 
Myosins are essential for CM contraction and consist of heavy and light chains (England and 
Loughna, 2013). Together with the onset of spontaneous contraction, expression of MYH6 and MLC2a 
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was observed at day 8 and maintained until day 15 (Fig. 13 C, D). Both are markers for fetal/immature 
as well as for atrial CM (England and Loughna, 2013; Hailstones et al., 1992; Reiser et al., 2001) and 
were stronger expressed with the Kadari protocol. 
 
 
Fig. 12: Comparison of the expression of immature cardiac marker genes between two protocols. 
Expression of TNNT2 (A), HCN4 (B), MYH6 (C) and MLC2a (D) was investigated via qRT-PCR at various days 
during differentiation according to Lian et al. (2013a; red, n = 6) and Kadari et al. (2015; green, n = 6 until day 5, 
n = 4 at day 8 and 15). Values were normalized to 18sRNA and for each target to the day 15-mRNA level 
achieved with the Lian protocol. Student’s t-test was performed among experiments. * p < 0.05; black symbols: 
target gene expression before differentiation; black lines: median; d, day. 
 
Marked differences between the two protocols were observed in the expression of chamber specific 
markers. Expression of MYH7 as well as MLC2v, marking more mature and ventricular CM (England 
and Loughna, 2013), was much higher in the cultures resulting from the Kadari protocol compared to 
those of the Lian protocol (Fig. 13 A, B). Likewise, expression of IRX4, another ventricular marker 
(Bao et al., 1999; Nelson et al., 2016), was higher with the Kadari protocol. In contrast, with the Lian 
protocol, its levels were generally low with CT-values near baseline level and it was only expressed at 
day 15 (Fig. 13 C). 
 - 30 - 
Atrial natriuretic factor (ANF) is a marker for initiation of working myocardium and is used as a 
marker for atrial development (Houweling et al., 2005). The expression of its gene, NPPA, was 
observed starting from day 8 with both protocols (Fig. 14 D), but with higher levels resulting from the 
Kadari protocol. Two other genes generally used as atrial markers, namely NR2F2 (Devalla et al., 
2015; Wu et al., 2013) and KCNA5 (Devalla et al, 2015) were investigated. For NR2F2, no protocol-
dependent differences were observed (App. Fig. 1 E). KCNA5 mRNA level was above baseline level 
starting from day 1 and peaked at day 2 with the Lian protocol. With the Kadari protocol, its 
expression was initiated at day 2, peaked at day 5 and was reduced afterwards (App. Fig. 1 D). By 
trend, its level was higher with the Kadari protocol from day 5 to 15. 
 
 
Fig. 13: Expression of chamber specific cardiac marker genes analyzed via qRT-PCR comparing two 
differentiation protocols. RNA samples were taken at multiple days during differentiation according to Lian et 
al. (2013a; red symbols; n = 6) and Kadari et al. (2015; green symbols; n = 6 until day 5, n = 4 at day 8 and 15) 
and analyzed for expression of MYH7 (A), MLC2v (B), IRX4 (C) and NPPA (D). Values were normalized to 
18sRNA and for each target to its highest expression level achieved with the Lian protocol. Black symbols: 
target gene level before differentiation; black lines: median; d, day.  
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In summary, cardiac marker gene expression was higher in the cultures derived from the Kadari 
protocol. This was especially obvious for the chamber specific markers MYH7, MLC2v and NPPA. 
 
3.1.2 Immunocytochemical analyses of the structural organization of cardiac proteins 
The CM derived from both protocols were additionally analyzed for the cardiac proteins α-Actinin, 
cTNT, MLC2a and MLC2v at day 15 of differentiation via immunocytochemistry. Both protocols led 
to their expression, except for MLC2v (Fig. 14). This protein was not expressed in the CM derived 
from the Lian protocol, while it was observed in some, but not all clusters resulting from the Kadari 
protocol. CM derived from the Kadari protocol had a higher level of protein organization, i.e. their 
sarcomeric structure was more pronounced.  
 
 
Fig. 14: Immunocytochemical detection of typical markers in H9-derived CM. H9 cells were differentiated 
according to the Lian (A) or Kadari (B) protocol. At day 15, cells were fixed and stained with antibodies against 
α-Actinin, cTNT, MLC2a and MLC2v. DNA was stained with Hoechst-33342. Scale bars: 10 µm.  
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3.1.3 Functional analyses of the beating cardiac clusters  
Functionality of the CM generated with both protocols was evidenced by the onset of spontaneous 
contractions between day 6 and 8 of differentiation. To assess their beating features, videos were 
recorded and analyzed with the software cBRA (Nitsch et al., 2018) for their beat rates and beat 
variability. In four out of n = 6 independent experiments, maximum five beating clusters were 
recorded. However, since the beat rates varied markedly within one experiment and among the clusters 
derived from one protocol, at least 20 videos per protocol were recorded in all subsequent 
experiments. The two experiments comparing the Lian and Kadari protocols with 20 videos per 
protocol showed opposing trends in terms of the beat rates (Fig. 15). 
 
 
Fig. 15: Beat rates of the H9-derived cardiac clusters. 20 videos were recorded per protocol (gray boxes: Lian 
protocol, white boxes: Kadari protocol) at day 8, 11 and 15 of differentiation and beat rates of the cardiac 
clusters were determined with the software cBRA. The results of two independent experiments are shown. 
Boxes, 25 % quartile – median – 75 % quartile. Whiskers, 1.5 coefficient. 
 
The videos were additionally analyzed for the beat variability of the cardiac clusters. Therefore, beat 
intervals and their standard deviations (SD1 and SD2) were determined and depicted in Poincaré plots 
as shown representatively in Fig. 16 A and B for the Lian and Kadari protocol, respectively. SD1 is 
the standard deviation of the long term variability and SD2 of the short term variability. A high SD1 
means that the beating became faster or slower during the video, whereas a high SD2 means that the 
beat intervals were very irregular. The beat variability of the clusters generated with the Lian protocol 
was high at each day of video recording (Fig. 16 C, E). The clusters resulting from the Kadari protocol 
showed a high beat variability at day 8, however, at day 15 it was very low (Fig. 16 D, F). 
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Fig. 16: Beat variability assessed with the software cBRA. A, B) Representative Poincaré plots of the clusters 
resulting from the Lian (A) and Kadari (B) protocol at day 15 of cardiac differentiation. C-F) At day 8 (black), 
11 (blue) and 15 (red) the same clusters were video-recorded to monitor their development over time. The 
medians of the standard deviations of the long term (C, D) and short term (E, F) variability were calculated and 
plotted for each cluster at each day for the Lian (C, E) and Kadari (D, F) protocol. Plots of one out of two 
independent experiments are shown.  
 
Presence and functionality of β-adrenoreceptors of the day 15-CM was investigated via addition of 
1 µM isoproterenol, a non-selective agonist of these receptors. Two clusters were recorded per 
protocol before and after its addition. In general, all clusters reacted with an increased beat rate 
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(App. Fig. 2). However, one of the two clusters derived from the Kadari protocol showed a delayed 
response: During the first two minutes upon addition of isoproterenol, its beat rate remained the same 
as before. Starting from ~ 3 min until the end of the video, it increased by around 24 %. At day 22 and 
29 of differentiation, the same cluster showed a normal response to isoproterenol (i.e. 1.4- and 1.8-fold 
increased beat rate, respectively). 
 
Since differentiation according to Kadari et al. (2015) led to a higher cardiac marker gene expression, 
a higher level of protein organization and a more regular beating, this protocol was used in all 
following experiments. 
 
3.2 Characterization of the cell line H9-hTnnTZ-pGZ-D2 and comparison to the wildtype H9 cell 
line 
The transgenic cell line H9-hTnnTZ-pGZ-D2 (cTNT-H9) has several advantages compared to the 
wildtype H9 cell line: it is adapted to feeder-free conditions and cardiac differentiation can easily be 
observed since GFP is under the control of the cTNT-promoter (Fig. 17). Before this cell line was 
routinely used, the cells were characterized with respect to their cardiac differentiation capability, their 
karyotype and response to X-ray irradiation compared to the wildtype H9 cell line. 
 
 
Fig. 17: cTNT-H9-derived cardiac cultures. A) Cardiac clusters were surrounded by non-cardiac cells that 
were morphologically distinguishable from non-cardiac cells. B) The CM express GFP, which is under the 
control of the cTNT-promoter, while non-cardiac cells do not fluoresce. Scale bar: 100 µm. 
 
3.2.1 Cytogenetic analyses of cTNT-H9 cells during ReleSRTM-passage and after X-ray exposure  
During prolonged culture of hESCs, chromosomal aberrations may accumulate, which is in part 
depending on the method of culture and passaging (Luft et al., 2017; Nguyen et al., 2013). In this 
study, several passaging methods were tested for the cTNT-H9 cell line, however, only passage with 
ReleSR
TM
 led to a high amount of pluripotent cells (data not shown). Since no cytogenetic analyses of 
the cTNT-H9 cells passaged with ReleSR
TM
 exist, their karyotype was analyzed at multiple passages 
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using mFISH. As depicted in Fig. 18 A, even cTNT-H9 cells of a high passage (i.e. p75) displayed a 
normal female karyotype consisting of 46 chromosomes. In 111 analyzed cells, no aberrant ones were 
detected.  
24 h after exposure to 1 Gy X-rays, 15.8 % of the cTNT-H9 cells showed chromosomal aberrations 
(15 aberrant out of 95 analyzed cells, Fig. 18 B). The most frequent aberrations were breaks 
(9.5 breaks per 100 cells) and translocations (5.3 %). Seven days after irradiation, only 3.3 % cells 
were aberrant. Additionally, cells irradiated with 2 Gy were analyzed seven days after exposure. 
However, due to a low number of mitotic cells, only 57 cells were analyzed. Four of them were 
aberrant including one complex aberration. The results of the cytogenetic analyses after X-ray 
exposure are summarized in App. Table 8. 
 
 
Fig. 18: Cytogenetic analyses of cTNT-H9 cells based on mFISH. A) cTNT-H9 cells at passage 75 had a 
normal female karyotype with 46 chromosomes. B) 24 h after exposure to 1 Gy, there are several aberrations, 
like translocations (t 4‘-15 + t 15‘-4) or acentric and truncated chromosomes (ace5 + T5’). 
 
3.2.2 Cell death upon X-ray exposure of cTNT-H9 cells 
24 – 72 h after exposure to 1 Gy, massive cell death was observed by many free-floating cells in the 
culture medium. To quantify necrotic and apoptotic cells, three independent experiments were 
performed and analyzed by means of the CellEvent
TM
 Caspase-3/7 Green Flow Cytometry Assay Kit. 
Fig. 19 shows the results of one representative experiment and the data of all three experiments are 
summarized in App. Table 9 and 10.  
24 and 48 h after exposure, the measured percentage of apoptotic cells was on average twice as high as 
in sham controls (Q4 in Fig. 19 A, B). The amount of necrotic cells (Q2) varied among experiments, 
but was by trend comparable between controls and irradiated samples. 72 h after irradiation, there 
were, in the mean, four times more apoptotic cells than in sham controls and the number of necrotic 
cells was increased two fold (Fig. 19 C). Compared to controls, there were substantially less living 
cells (Q3) at 48 and 72 h after irradiation. This is in line with the smaller colony size at these time 
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points. However, it has to be taken into account that the medium was changed every 24 h. Therefore, 
the number of dead cells determined 48 and 72 h after irradiation represents only those cells that 
initiated cell death in the last 24 h before measurement and not the overall amount of dead cells since 
irradiation. 
 
 
Fig. 19: FACS-based quantification of the necrotic and apoptotic fraction of cTNT-H9 cells upon 
irradiation. Cells were irradiated (sham or 1 Gy X-rays) and stained with the CellEvent
TM
 Caspase-3/7 Green 
Flow Cytometry Assay Kit after 24 h (A), 48 h (B) and 72 h (C) for apoptotic (Q4) and necrotic (Q2) cells. 
Living cells (Q3) were unstained.  
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3.2.3 Comparison of the cardiac differentiation efficiency using the H9 and cTNT-H9 cell lines 
H9 and cTNT-H9 cells were differentiated according to Kadari et al. (2015) in two independent 
experiments. In the cTNT-H9 cultures, more beating cardiac clusters formed compared to the H9 
cultures. This observation was confirmed by marker gene expression analyses (Fig. 20). Whereas at 
day 2, the early mesodermal marker T was expressed at the same level with both cell lines (Fig. 20 A), 
markedly increased gene expression levels were observed starting from the cardiac progenitor stage 
(NKX2.5, Fig. 20 B) to the immature CM (Fig. 20 C - E) using the cTNT-H9 cells. One exception was 
the pacemaker marker HCN4: its expression was the same at day 8 in both cell lines. However, at day 
15 it was slightly (experiment 1, data not shown) or significantly higher (experiment 2, Fig. 20 F) in 
the cTNT-H9 cultures.  
Beat rates of the H9 and cTNT-H9 cultures were the same (App. Fig. 3). The only exception was that 
in two out of three independent experiments the cTNT-H9-derived clusters were beating significantly 
faster at day 11 than those derived from the wildtype cell line. 
 
These results suggest that cardiac differentiation is more efficient using the cTNT-H9 cells. Therefore, 
all subsequent experiments were performed with this cell line. 
 
Cardiac clusters derived from the cTNT-H9 cells detached to a very high extent from the Matrigel®-
coated culture plates in all experiments and were thus removed when medium was exchanged. Since 
this was not the case when the plates were instead coated with Geltrex®, cTNT-H9 cells were 
differentiated on Geltrex®-coated plates in all subsequent experiments. 
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Fig. 20: Marker gene expression of H9- and cTNT-H9-derived cardiac cultures grown on Matrigel®. 
Expression levels of T (A), NKX2.5 (B), TNNT2 (C), MYH7 (D), MLC2v (E) and HCN4 (F) were compared via 
qRT-PCR analyses at various days of differentiation of H9 (black bars) and cTNT-H9 (green bars) cells. Values 
were normalized to 18sRNA and to the highest expression level of each target gene achieved with the H9 
wildtype cells. Results of one out of two independent experiments are shown. Statistical significance was 
determined for all values above baseline level by Student’s t-test within one experiment. * p < 0.05, ** p < 0.01, 
*** p < 0.001; d, day. 
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3.3 Impact of exposure to various X-ray doses on cardiac differentiation of cTNT-H9 cells 
Preliminary experiments with the H9 cells indicated that 1 Gy X-rays lead to decreased cardiac gene 
expression at all differentiation stages starting from T to MLC2v compared to controls (App. Fig. 4), 
but no overall effect was detected regarding the beat rates (n = 4) and all clusters were responding to 
isoproterenol (data not shown). 
Pluripotent cTNT-H9 cells were irradiated with 0 (sham), 0.1, 1 or 2 Gy and seven days later, cardiac 
differentiation was initiated. From n = 8 experiments, there was one outlier experiment with marker 
gene expressions clearly differing from the other seven experiments and thus, it was not taken into 
account for the comparison. In another experiment, cardiac differentiation of cTNT-H9 cells exposed 
to 0.1 Gy failed. Here, starting from MESP1, all cardiac markers were significantly decreased. 
Therefore, only six out of eight experiments were considered to investigate the impact of 0.1 Gy and 
data of seven experiments were compared for the 1 and 2 Gy doses.  
Upon irradiation with 2 Gy, massive cell death occurred already within the first 24 h as indicated by a 
high number of free-floating cells in the culture medium. The surviving colonies were very small 
compared to control (App. Fig. 5). To seed the same amount of cells for differentiation initiation, more 
petri dishes were prepared for the 2 Gy irradiation. Still, in two experiments the cell number was not 
sufficient and therefore, no RNA sample could be taken for 2 Gy at one (or two) time point(s). 
Pluripotency before initiation of differentiation (day 0) was evidenced via immunocytochemical 
detection of OCT4, SOX2 and NANOG protein (data not shown). 
 
3.3.1 qRT-PCR based analyses of cardiac marker genes upon exposure of pluripotent cTNT-H9 cells  
The pluripotency markers POU5F1 and NANOG were expressed in undifferentiated cells. Upon 
initiation of differentiation, their level was steadily decreased and at day 5, they were no longer 
expressed (App. Fig. 6 A, B). No general radiation-induced alteration of their expression was observed 
in the pluripotent cells at day -4, however, at day 0, their expression was by trend reduced upon the 1 
and 2 Gy exposure.  
 
For all following markers, dose effect-curves are shown at those day(s) when their expression was 
above baseline levels. For a detailed time course of their expression for each experiment, column 
scatter plots are depicted in the appendix (App. Fig. 6 and 7). 
 
At day 2, no alterations were detected for T expression upon irradiation with any dose (Fig. 21). 
MESP1 expression was not affected by 0.1 Gy, however, upon 1 Gy, it was decreased in five 
experiments and 2 Gy led to its reduction in all seven experiments (Fig. 21). 
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Fig. 21: Dose effect-curves of T and MESP1 expression at day 2 of differentiation. cTNT-H9 cells were 
irradiated with 0 (sham control), 0.1, 1 or 2 Gy X-rays and seven days later, they were differentiated. Expression 
of T (black) and MESP1 (red) at day 2 was analyzed via qRT-PCR. Values were normalized to 18sRNA and to 
the expression level of controls at day 2 of each gene in each experiment. Medians with the standard error of the 
median are shown. Student’s t-test was performed among experiments; * p < 0.05; ** p < 0.01. 
 
NKX2.5 expression was not affected at day 5 and 8 by 0.1 and 1 Gy exposure (Fig. 22 A). However, at 
day 15, it was decreased upon both doses and upon 2 Gy, it was decreased at day 8 and 15. 
Already before differentiation, HCN4 mRNA was detected (App. Fig. 6 F). When cardiac 
differentiation was initiated, its expression first decreased, then increased again after day 5 
accompanying the onset of spontaneous beating between day 6 to 8. By trend, HCN4 amount was 
decreased at day 15 in cultures derived from irradiated cTNT-H9 cells (Fig. 22 B).  
 
TNNT2 expression appeared at day 5 and peaked at day 15 (Fig. 22 C). Starting from day 6, GFP-
fluorescence could be observed in the cardiac clusters at the microscope confirming the expression of 
cTNT. Upon 0.1 Gy, no significant changes were observed at day 8, however, at day 15, in five out of 
six experiments TNNT2 expression was decreased at least 2.0-fold. At day 8 and 15, it was decreased 
upon 1 Gy in six out of seven experiments, and upon 2 Gy in all seven experiments. 
 
Markers of immature, but also atrial CM, namely MYH6, MLC2a and NPPA appeared at day 8 and 
peaked at day 15 in control samples (Fig. 22 D - F), whereas more mature and ventricular markers, 
MYH7 and MLC2v, were detected only at day 15 (Fig. 23).  
Exposure to 0.1 Gy did not lead to altered MYH6, MLC2a and NPPA expression at day 8 (Fig. 22 D -
F). However, at day 15 expression of all three markers was reduced. 
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Fig. 22: Expression of cardiac marker genes in differentiating cTNT-H9 cells upon exposure to various X-
ray doses. Seven days after irradiation with 0 (sham control), 0.1, 1 or 2 Gy X-rays, cTNT-H9 cells were 
differentiated. Dose effect-curves are shown for NKX2.5 (A), HCN4 (B), TNNT2 (C), MYH6 (D), MLC2a (E) 
and NPPA (F) expression at day 8 (gray) and 15 (black) of differentiation as analyzed via qRT-PCR. Values 
were normalized to 18sRNA and to the expression level of controls at day 15 for each gene in each experiment. 
Medians with the standard error of the median are shown and statistical significance among experiments was 
determined with Student’s t-test; * p < 0.05; ** p < 0.01; *** p < 0.001; d, day. 
 
In cultures derived from 1 Gy-irradiated cTNT-H9 cells, cardiac gene expression varied strongly 
among experiments (Fig. 22 D - F and Fig. 23). However, by trend all of them were decreased 
compared to controls. This was even more pronounced upon exposure to 2 Gy where a clear reduction 
of MYH6, MLC2a, NPPA, MYH7 and MLC2v expression was detected.  
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Fig. 23: Expression of ventricular marker genes at day 15 of differentiation of irradiated cTNT-H9 cells. 
Seven days after irradiation with 0 (sham control), 0.1, 1 or 2 Gy X-rays, cTNT-H9 cells were differentiated. 
Expression of MYH7 (black) and MLC2v (red) were analyzed via qRT-PCR. Values were normalized to 18sRNA 
and for each target gene to expression levels of controls at day 15. Student’s t-test was performed among 
experiments; ** p < 0.01; *** p < 0.001; d, day. 
 
3.3.2 Impact of the exposure on the expression and structural organization of cardiac proteins  
To investigate whether X-ray exposure of hESCs has an impact on the structural organization of 
cardiac proteins, α-Actinin, cTNT and MLC2a were investigated via immunocytochemistry in the day 
15-CM. The sarcomeric structures needed for contraction were observed and no difference between 
controls and irradiated samples was detected (data not shown).  
In contrast to controls and CM derived from 0.1 and 1 Gy-irradiated cTNT-H9 cells, those derived 
from 2 Gy-irradiated cells did not express MLC2v protein (Fig. 24). 
HCN4 was stained, too, but the signal was not clearly distinguishable from noise (App. Fig. 8). A 
positive control of the antibody confirmed its specific binding to HCN4, however (App. Fig. 9). 
Gap junctions allow the propagation of electrical activity in the heart and are built up of connexins, 
with Cx43 being the most abundant one in the mammalian heart (Gros and Jongsma, 1996). Its 
immunocytochemical detection revealed only few Cx43-foci in the cell membranes of the CM 
(Fig. 25, right side; representative picture of controls) and no differences between controls and 
irradiated cells were detected. In non-cardiac cells, the Cx43-signal was stronger not only in the 
membranes, but also in the whole cytoplasm and more concentrated near the nucleus (Fig. 25, upper 
left side), however, no foci as in the cardiac cell membranes were detected. 
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Fig. 24: MLC2v protein expression in sham and irradiated cTNT-H9-derived CM. cTNT-H9 cells were 
exposed to 0, 0.1, 1 or 2 Gy X-rays and seven days later they were differentiated. At day 15 of differentiation, 
cells were fixed and stained for MLC2v (red). DNA was counterstained with Hoechst-33342 (blue). Green, GFP-
expressing CM. Scale bars: 10 µm. 
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Fig. 25: Connexin 43 in cTNT-H9-derived cardiac cultures. At day 15 of differentiation, cardiac cultures 
were fixed and stained for Cx43 (A). B) Merged picture with DNA (blue) and GFP-expressing cTNT-H9-
derived CM (green). Scale bar: 10 µm. 
 
3.3.3 Functional analyses of beating cardiac clusters derived from exposed cTNT-H9 cells 
Beat rates of the cardiac clusters were analyzed at day 8, 10 (or 11) and 15 of differentiation with the 
software cBRA (Nitsch et al., 2018) and results of each experiment are depicted in Fig. 26 since 
results varied greatly among experiments. In general, no marked overall differences were observed in 
the beat rates of control clusters and those derived from 0.1 and 1 Gy-irradiated cTNT-H9 cells. 
However, in one experiment (Fig. 26 A), a low differentiation efficiency was observed following the 1 
Gy exposure: only ten beating clusters developed until day 8 with beat rates comparable to controls 
and twelve clusters until day 15 with a significantly lower mean beat rate. 
Beat rates derived from cells exposed to 2 Gy were distinguishable from controls in most experiments: 
in one experiment no beating clusters were detected at day 8, one at day 10 and three at day 15 
(Fig. 26 A), in two other experiments they were beating faster at day 15 compared to controls 
(Fig. 26 B, C) and in another one, they were beating faster at day 8 and spanning a smaller range than 
controls at day 15 (Fig. 26 D).  
In two experiments (Fig. 26 D, E) a different cluster morphology was observed: Here, only few 
compact round clusters formed, but rather thin layers of CM (App. Fig. 10 A - C) that were - in some 
samples - spanning almost the whole culture dish starting from day 10. Thereby, the majority of the 
CM was connected with each other and beat rates were beyond physiological rates (between 150 and 
more than 300 bpm).  
As stated previously, in the last experiment (Fig. 26 E), differentiation of the 0.1 Gy irradiated cTNT-
H9 was not successful: at day 8 no cardiac clusters were detected, at day 11 there was one and at 
day 15 there were five beating clusters with a “normal” morphology (i.e. compact beating clusters, 
App. Fig. 10 D). 
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Analyses of the beat variability did not show a significant IR-induced effect. Instead, for each 
experiment a different trend was observed (data not shown).  
 
 
Fig. 26: Beat rates of cardiac clusters derived from cTNT-H9 cells exposed to various X-ray doses. 
Pluripotent cTNT-H9 cells were irradiated with 0 (control, black boxes) 0.1 (dark gray boxes), 1 (light gray 
boxes) and 2 Gy (white boxes) and differentiated seven days later. At day 8, 10 or 11 and 15 of differentiation, 
videos of the beating clusters were recorded and analyzed with the software cBRA. Each plot shows the results 
of one experiment. Statistical significance was determined with Student’s t-test, * p < 0.05; ** p < 0.01; 
*** p < 0.001. Boxes, 25 % quartile – median – 75 % quartile. Whiskers, 1.5 coefficient. 
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3.3.4 Impact of isoproterenol on cardiac clusters derived from irradiated cTNT-H9 cells 
Addition of 1 µM isoproterenol led to a positive chronotropic response of the cardiac clusters in 
controls (Fig. 27 A) and irradiated cultures (Fig. 27 B - D). Only one cluster derived from cTNT-H9 
cells exposed to 0.1 Gy showed a rather abnormal beat rate before and no enhanced beat rate after 
addition of isoproterenol (Fig. 27 B, cluster #8). Furthermore, two clusters derived from 1 Gy- 
(Fig. 27 C, cluster #3, 4) and one cluster derived from 2 Gy-irradiated cells (Fig. 27 D, cluster #4) did 
not increase their beat rates. However, when the same clusters were analyzed one and two weeks later 
(at days 22 and 29), their beat rates increased upon addition of isoproterenol (data not shown). 
Control clusters were beating around 43 % upon addition of isoproterenol and those derived from 0.1 
or 1 Gy-irradiated cTNT-H9 cells were beating about 54 % or 51 % faster, respectively. The lowest 
increase was observed after the 2 Gy exposure: clusters were beating only about 25 % faster with 
isoproterenol. 
 
 
Fig. 27: Increased beat rates upon addition of isoproterenol to cardiac cultures derived from irradiated 
cTNT-H9 cells. Seven days before initiation of cardiac differentiation, cTNT-H9 cells were exposed to 0 (sham 
control, A), 0.1 (B), 1 (C) and 2 Gy X-rays (D). At day 15 of differentiation, videos of beating cardiac clusters 
were recorded before (black) and after addition of 1 µM isoproterenol (red). For each dose, the mean difference 
(Δ) of the beat rates is indicated with the standard error of the mean in percent. 
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3.4 qRT-PCR array-based pathway analyses of alterations in Stem Cell and DNA Damage 
Response Signaling upon X-ray exposure of cTNT-H9 cells 
To investigate possible mechanisms underlying the described alterations in cardiac markers upon X-
ray irradiation (see section 3.3), pluripotent cTNT-H9 cells were irradiated with 1 Gy and RNA 
samples were collected after 1 h, 6 h, 24 h and 7 days in n = 6 independent experiments. The samples 
for each time point were pooled and analyzed with a qRT-PCR array containing 84 different primers 
for targets either of Stem Cell Signaling (SCS) or of DNA Damage Response (DDR) Signaling. For 
analyses, pooled controls for each time point were set as one control group automatically. 
 
3.4.1 Alterations in Stem Cell Signaling 
Three of the proposed housekeeping genes were used for normalization (GAPDH, HPRT1, RPLP0). 
1 h after exposure to 1 Gy, drastic gene expression changes occurred with most genes being 
upregulated compared to controls (Table 6 and App. Fig. 11). SP1 was markedly affected with a 42-
fold downregulation. Most genes with altered expression levels belong to TGF-β signaling and WNT 
signaling, but also FGF, NOTCH and Sonic Hedgehog signaling were affected. 6 h and 24 h after 
exposure, the expression of many genes was decreased compared to controls and 7 d after exposure, 
many genes were again upregulated with the most dramatic changes in gene expression of the activin 
receptors ACVR1, ACVR1B/C (5.0- to 8.0-fold upregulation) and ACVR2A/B (18- and 12-fold 
upregulation, respectively) and of FZD3 (13-fold upregulation).  
 
It has to be mentioned that sham controls of each time point were treated as one group by the 
algorithm in the Data Analysis Center at www.qiagen.com. However, it was not clear how they were 
summarized. Individual analysis of each sham control revealed that their gene expressions varied 
markedly. Especially 1 h after sham irradiation, many genes were elevated compared to controls of 
later time points (data not shown). Since cardiac differentiation was initiated seven days after 
irradiation in this study, this time point was further investigated. Gene expression changes were again 
analyzed comparing only the sham control of day 7 with the respective irradiated sample. Most genes 
that were already identified to be upregulated, were confirmed with this method. Still, six of them 
were not confirmed (CREBBP, FZD1/8/9, IL6ST, LTBP3), but four additional ones were found (FZD5, 
GLI1, NFATC3, SMAD1). 
 
Genes connected to (early) cardiac differentiation that were upregulated seven days after irradiation 
according to the qRT-PCR array are listed in Table 7 and were further investigated in each of the 
samples that were pooled for the arrays (subsequently termed “individual array samples”) and in the 
samples of the experiments described in section 3.3.  
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Table 6: Stem Cell Signaling-related genes with altered expression levels after exposure to 1 Gy X-rays 
compared to sham controls at different time points (all sham controls were calculated as one control group). 
Genes whose expression is altered more than 2-fold are shown (black: upregulated, blue: downregulated) 
 
1 h 6 h 24 h 7 d 
FGF signaling FGFR1-4, STAT3 FGFR1-3 
STAT3 
 
FGFR3/4, 
FGFR1-3, STAT3 
TGF-β signaling 
ACVR1, 
ACVR1B/C, 
ACVR2A/B, 
ACVRL1, AMHR2, 
BMPR1A/B, 
BMPR2, ENG, 
LTBP3/4, (RGMA), 
SMAD7/9, 
TGFBRAP1 
LTBP1, 
SMAD1 
 
ACVR1C, 
ACVR2A/B, 
BMPR1A, 
BMPR2, ENG, 
SMAD6 
LTBP1-4, 
SMAD3/7, 
TGFBR2/3 
 
ACVR1, 
ACVR1B/C, 
ACVR2A/B, 
BMPR1A/B, 
BMPR2, 
ACVR1, ACVR1B/C, 
ACVR2A/B, ACVRL1, 
BMPR1A/B, BMPR2, 
ENG, LTBP1/3 
 
SMAD6, TGFBRAP1 
WNT signaling 
BCL9, BCL9L, 
CTNNB1, 
FZD1/2/7/8/9, 
LEF1, LRP5, 
PYGO2 
 
FZD3 
FZD3, LRP5/6 
 
BCL9, BCL9L, 
CTNNB1, 
FZD1/2/7, 
LEF1 
FZD3, LRP6, 
TCF7 
 
BCL9, BCL9L, 
CTNNB1, FZD1/2, 
LEF1 
BCL9, BCL9L, 
CTNNB1, FZD1/3/6-9, 
LEF1, LRP6 
NOTCH signaling 
EP300, NOTCH1/3, 
PSEN2, PSENEN 
NOTCH1/2 
 
EP300 
NOTCH1/2 
 
EP300 
EP300, NOTCH1/2 
Sonic Hedgehog 
signaling 
GLI1-3, SMO   
GLI2/3 
 
SMO 
Other 
CDX2, CREBBP, 
E2F5, EP300, 
IL6ST, NFATC1/3, 
PTCHD2, RBL1, 
RBPJL, RGMA, 
STAT3 
 
SP1 
CREBBP, 
LIFR, 
NFATC4, 
RBL2, SP1 
 
EP300 
LIFR, STAT3, 
NFATC1/4, RBL2, 
RBPJL, SP1, 
STAT3 
 
CREBBP, E2F5, 
EP300 
CREBBP, E2F5, 
EP300, IL6ST, LIFR, 
NFAT5, NFATC1/4, 
RBL2, SP1, STAT3 
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Table 7: Stem Cell Signaling-related genes which were more than 2-fold upregulated 7 days after irradiation and 
connected to cardiac development. 
Upregulated gene Link to cardiac development Reference/species 
FGFR1 crucial in heart development Dell’Era et al., 2017 (mouse) 
IL6ST activation of gp130 leads to 
phosphorylation of STAT3 which directly 
controls NKX2.5 expression 
Snyder et al., 2010 (mouse) 
LEF1 OCT4 and TCF/LEF bind to Mesp1 
promoter leading to its expression 
Li et al., 2013 (mouse) 
NOTCH1 inhibits mesoderm formation Schroeder et al., 2006 (mouse) 
SP1 involved in control of Mesp1 expression Beketaev et al., 2015 (mouse) 
 
3.4.2 Verification of the SCS-array results 
FGFR1 
The 6.4-fold upregulation of FGFR1 seven days after irradiation observed with the SCS-array could 
not be confirmed via individual qRT-PCR (data not shown). Analyzing the experiments of section 3.3 
for FGFR1, no marked differences between pluripotent and differentiated cells were observed 
(App. Fig. 12 A) as well as between control, 0.1 and 1 Gy-irradiated samples. An altered amount of 
FGFR1 mRNA was, by trend, detected at day 2, 5 and 15 following the 2 Gy exposure, however, the 
magnitude of the alteration was low. 
 
IL6ST 
Activation of glycoprotein 130 (gp130), the receptor protein encoded by IL6ST, leads to the activation 
of STAT3 also in the heart (Fischer and Hilfiker-Kleiner, 2008). According to the results of the SCS-
array, IL6ST expression was increased 2.1- to 3.5-fold 1 h and 7 d after irradiation with 1 Gy. qRT-
PCR analyses of the individual array samples did not confirm these results (data not shown).  
In the experiments described in section 3.3 (n = 7) IL6ST expression steadily increased until day 15 
(Fig. 28). In cultures derived from exposed cTNT-H9 cells, IL6ST expression was decreased in all but 
one experiment at day 8 and 15. Following the 2 Gy exposure, the trend of its reduction was already 
visible at day 2 (low magnitude) and at day 8 it was reduced with statistical significance according to 
Student’s t-test within three experiments and at day 15 within six experiments.  
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Fig. 28: qRT-PCR-based expression analyses of IL6ST during cardiac differentiation of irradiated cTNT-
H9 cells. Cells were irradiated with 0 (sham control), 0.1, 1 and 2 Gy X-rays and seven days later, differentiation 
was initiated (n = 7). Values were normalized to 18sRNA and day 15-control levels in each experiment. Medians 
with the standard error of the median are shown. Student’s t-test was performed among experiments; ** p < 
0.01, *** p < 0.001; d, day.  
 
LEF1 
Expression of LEF1 was very low in the SCS-array (CT-values between 28 and 32). qRT-PCR of the 
individual array samples showed that LEF1 was nearly not detectable (data not shown). Also in the 
experiments of section 3.3, it was not expressed in the pluripotent cells. However, with initiation of 
differentiation, its expression appeared at day 2 and peaked at day 5 in controls. No differences were 
observed between controls, 0.1 and 1 Gy-irradiated samples at these time points. However, the 2 Gy-
exposed cells showed an increased level at day 2 and 5. At day 15, there was a low magnitude-
reduction of LEF1 mRNA in the 1 and 2 Gy-irradiated cells (App. Fig. 12 B). 
 
NOTCH1 
NOTCH1 levels were very low according to the SCS-array. In contrast, it was clearly expressed in the 
individual array samples, but no IR-induced effect was detected up to 7 days (data not shown). In the 
experiments of section 3.3, NOTCH1 mRNA was already present in the pluripotent cells and during 
differentiation, its level varied with low magnitude. No radiation-induced effects were detectable, 
except for the day 15 samples resulting from the 2 Gy-irradiated cells showing an increased amount of 
NOTCH1 mRNA by trend (App. Fig. 12 C). 
 
SP1 
According to the SCS-array, SP1 expression was downregulated 1 h after irradiation. However, CT-
values were low in controls and no expression was detected in the irradiated samples at this time point. 
Changes in CT-values at 6 h, 24 h and 7 d were of low magnitude and normalization resulted in a 4.9-
   
  - 51 - 
fold increase of SP1 in irradiated samples after 7 d. Individual qRT-PCR analyses did not confirm this, 
instead, SP1 expression varied and no overall effect was observed (data not shown).  
Investigating SP1 expression in the experiments described in section 3.3 did not show any alterations, 
neither between pluripotent and differentiated cells, nor between controls and irradiated samples (App. 
Fig. 12 D). 
 
ACVR1B and ACVR2B 
Using the same SCS-array, Luft et al. (2017) demonstrated the downregulation of activin receptors, 
like ACVR1/2B, 24 h after irradiation of H9 cells. Comparable results were obtained at 24 h post 
exposure in the study at hand using cTNT-H9 cells. However, analyses of the individual array samples 
for ACVR2B did not confirm this. Likewise, the 11-fold increase at day 7 revealed by the array, was 
not confirmed (App. Fig. 13 A). Instead, in two experiments, there was a 2.0- and 3.0-fold decrease in 
ACVR2B mRNA.  
CT-values for ACVR1B were very low in the individual array samples. The 5.0-fold increase seven 
days after irradiation, which was observed with the array, was not confirmed (App. Fig 13 B).  
 
3.4.3 Alterations in DNA Damage Response Signaling 
Depending on the normalization method, the results differed based on the sensitivity of the method. 
Therefore, two methods were chosen and compared. In one approach, values were normalized to the 
housekeeping genes B2M, GAPDH and HPRT1 (method 1); in the other approach, values were 
normalized to genes whose expressions did not change among all samples, namely NBN, FEN1, 
PPP1R15A, FANCA and H2AFX (method 2). Comparison of the two normalization methods led to an 
overlapping set of multiple genes whose levels were altered at least 2-fold upon irradiation (Table 8).  
Generally, method 1 was more sensitive than method 2.  
 
At 1 h after exposure, all 14 genes that were revealed to be upregulated with method 2, were also 
identified with method 1. However, the latter resulted in additional 21 upregulated genes.  
Five of the 14 genes are related to apoptosis, four to cell cycle (CDKN1A, which encodes p21, is 
related to both, apoptosis and cell cycle) and four to various DNA repair pathways. Furthermore, the 
genes encoding ATM and ATR, which are known DNA damage sensors, as well as BARD1 and 
BRCA1, whose proteins form a complex to regulate a variety of functions (Gudmundsdottir and 
Ashworth, 2006), were upregulated. XPA and XPC were decreased according to both methods. 
However, CT-values of these two genes were low in controls and irradiated samples, indicating that 
they were almost not expressed. Therefore, they were not taken into account for further analyses. 
Results at 6 h after irradiation varied the most between the two methods. Only 4 genes were found to 
be upregulated with both methods and their proteins are involved in apoptosis, cell cycle and 
Nucleotide Excision Repair pathway (NER). Only one gene, namely MAPK12, was downregulated. 
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24 h after exposure, 12 genes were upregulated with both methods, among them ATM and ATR. Most 
of the other upregulated genes are related to cell cycle and apoptosis.  
Seven days after exposure, there was again a very high number of upregulated genes. 18 genes were 
upregulated according to both methods, among them ATM, ATR, BARD1 and BRCA1. Most of the 
other upregulated genes are related to cell cycle and apoptosis.  
 
Table 8: DNA Damage Response Signaling-related genes with more than two-fold altered expression levels 
according to both normalization methods after irradiation of cTNT-H9 cells (black: upregulated genes; blue: 
downregulated genes). 
 
1 h 6 h 24 h 7 d 
Apoptosis 
BAX, BBC3, 
CDKN1A, DDIT3, 
GADD45G 
BBC3, 
CDKN1A 
BAX, BBC3, 
CDKN1A 
BBC3, CDKN1A, 
CSNK2A2 
Cell cycle 
BARD1, CDC25C, 
CDK7, CDKN1A 
CDKN1A, 
HUS1 
CDC25C, CDK7, 
CDKN1A, 
GADD45A, HUS1 
BARD1, CDC25C, 
CDK7, CDKN1A, 
CSNK2A2, HUS1, 
MCPH1, RAD17 
DNA damage sensors 
ATM, ATR  
 
(XPC) 
  ATM, ATR ATM, ATR 
DNA repair BER APEX1   APEX1 APEX1 
  
DSB-
repair 
BLM, BRCA1   BRCA1 BLM, BRCA1 
  MMR       EXO1, MBD4 
  NER 
DDB2 
 
(XPA, XPC) 
DDB2 DDB2 DDB2 
Genomic stability BARD1, BRCA1   BRCA1 BARD1, BRCA1 
Other   (MAPK12)   ATRX, CSNK2A2  
 
3.4.4 Verification of the DDR-array results 
ATM 
ATM expression was increased at 1 h, 24 h and 7 d after irradiation according to the DDR-array. In 
three out of the six experiments that were pooled for the array, its expression was investigated via 
individual qRT-PCR. Unlike the results of the array, ATM expression remained at the same level as in 
controls except for one experiment (App. Fig. 14, Experiment 1). 
In addition, ATM protein expression was investigated via immunocytochemistry seven days after 
irradiation in cells that were seeded only for this purpose. No marked difference between controls and 
irradiated samples were observed at the microscope (App. Fig. 15). To analyze the intensity of the 
ATM-signal, 20 Z-stacks were taken using the same exposure time in sham and irradiated samples and 
intensity was measured in average intensity projections with the software Fiji. The measurements 
revealed a trend towards an increased ATM-signal intensity upon irradiation (App. Table 11), 
however, this effect was not statistically significant according to Student’s t-test. 
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CDKN1A 
qRT-PCR analyses of CDKN1A expression in the individual array samples confirmed the results of the 
DDR-array by trend: At 1, 6 and 24 h after irradiation, CDKN1A expression was markedly increased 
in the irradiated samples compared to controls in most of the six experiments (Fig. 29). However, 
seven days after irradiation, CDKN1A expression was not elevated compared to controls anymore. 
 
 
Fig. 29: Individual qRT-PCR analyses of CDKN1A expression. cTNT-H9 cells were irradiated with 0 (sham 
control) or 1 Gy X-rays and RNA samples were taken at 1 h, 6 h, 24 h and 7 d after irradiation (n = 6). 
 
At day 7 after irradiation, immunocytochemical staining of p21 was performed to verify the results of 
the array (7.0- to 8.8-fold increase seven days post irradiation). Neither in controls nor in 1 Gy-
irradiated cells p21 protein was observed (App. Fig. 16).  
 
3.5 Impact of an X-ray exposure on important signaling pathways of cardiac differentiation 
Cardiac differentiation is the result of a complex interaction between several signaling pathways. As 
shown in section 3.3, differentiation is impaired by an X-ray exposure of the hESCs. In addition to the 
qRT-PCR-arrays of the previous chapter, WNT signaling as well as miR-1 expression were 
investigated in order to reveal further mechanisms that are impaired by X-ray exposure. 
 
3.5.1 WNT signaling 
WNT11-mediated non-canonical WNT signaling plays a crucial role in cardiac differentiation 
(Mazzotta et al., 2016; Pandur et al., 2002b; Terami et al., 2004). Its expression was investigated via 
qRT-PCR in the experiments described in section 3.3. WNT11 was markedly expressed at day 5 and 
peaked at day 8 (Fig. 30 A). Irradiation of the cTNT-H9 cells with 0.1 Gy led to a rather decreased 
expression at day 8, and at day 15 this reduction was enhanced. Upon exposure to 1 and 2 Gy, there 
was a clear and statistically significant reduction of WNT11 mRNA level from day 5 to 15.  
 - 54 - 
Expression of another WNT-member involved in the non-canonical pathway, namely WNT5B, did not 
reveal an IR-induced effect (Fig. 30 B). Only at day 15, its expression was decreased by trend in 
cultures derived from 2 Gy-irradiated cells. 
 
 
Fig. 30: Expression of WNT11 and WNT5B during cardiac differentiation of cTNT-H9 cells upon 
irradiation. Seven days before initiation of differentiation, cTNT-H9 cells were exposed to 0 (sham control), 
0.1, 1 or 2 Gy X-rays. Dose effect-curves of WNT11 (A) and WNT5B (B) expression at several days of 
differentiation are shown. Values were normalized to 18sRNA and to control samples with the highest 
expression level. Medians with the standard error of the median are shown and Student’s t-test was performed 
among experiments; * p < 0.05, ** p < 0.01; d, day. 
 
On the protein level, no difference in WNT11 expression was observed between controls and 
irradiated samples at day 15 (see App. Fig. 17 D for exemplary picture of controls). Instead, a time-
dependent difference was observed between day 5, 8 and 15 samples. In cells with low GFP-levels 
(indicating the onset of cTNT expression) at day 5 and 8, WNT11 was detected all over the cells and it 
accumulated in several foci per cell (App. Fig. 17 A, B). The surrounding non-GFP cells showed a 
similar pattern, but the nuclear WNT11 signal was lower compared to GFP cells. In contrast, cells 
with a high GFP-level at day 8 and 15, which were already beating, showed a different pattern: 
whereas there was a uniform higher signal in the nucleus of most of these cells, no foci were detected 
anymore. However, the surrounding non-GFP cells had a low overall WNT11 signal, but showed a 
few (or at least one) big foci mostly near the nucleus (App. Fig. 17 C, D). 
 
3.5.2 microRNA-1 
miR-1 plays a central role in cardiac development (Fu et al., 2011; Zhao et al., 2007, 2005). Its 
expression was investigated via qRT-PCR analyses of the experiments described in section 3.3. Before 
initiation of differentiation, miR-1 was not detected in controls and irradiated samples (data not 
shown). It first appeared at day 8 and increased until day 15. (Fig. 28 A). For the 1 Gy samples, there 
was a consistent trend towards a decreased miR-1 expression. In contrast, the data were inconclusive 
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for the 0.1 and 2 Gy samples: in three out of six experiments, the amount of miR-1 was reduced, in the 
other three, it was several fold increased compared to controls leading to high standard errors. 
 
 
Fig. 31: miR-1 expression at day 8 and 15 of cardiac differentiation of irradiatied cTNT-H9 cells. Cells 
were irradiated with 0 (sham control), 0.1, 1 or 2 Gy X-rays and one week later, cardiac differentiation was 
initiated. At day 8 and 15, RNA samples were investigated via qRT-PCR for miR-1 expression. Values were 
normalized to SNORD25-11 and to day 15-control levels. Medians with the standard error of the median are 
shown and statistical significance was determined via Student’s t-test among experiments, ** p < 0.01; d, day. 
 
3.6 Contribution of the pacemaker channel HCN4 to the spontaneous beating of the cardiac clusters 
HCN4 is the major isoform of the HCN-family in the human sinoatrial node and, thus, it is used as a 
marker for pacemaker cells. To investigate the presence of pacemaker cells in the cardiac cultures 
resulting from the Kadari et al. protocol, HCN4 expression was analyzed on the mRNA (Fig. 12 B and 
Fig. 22 B) and protein level (App. Fig. 8). Irradiated cells showed a lower mRNA level of HCN4 than 
controls (Fig. 22 B). However, HCN4 protein signal was hardly distinguishable from noise in the 
cardiac cultures. Cells with a distinct signal were rare and only present in or near a few clusters. Some 
of these cells also had a morphology that was different from the cardiac cells and no GFP-cTNT was 
expressed (App. Fig. 8). Therefore, it was not clear whether these cells were cardiac pacemaker cells 
or neuronal cells, which also express HCN4 (He et al., 2014). To investigate its contribution to the 
spontaneous beating of the cardiac clusters at day 15, their electrophysiological properties as well as 
the effect of ivabradine, a specific blocker of the If-current mediated by HCN channels, were 
investigated.  
 
3.6.1 Electrophysiological properties of cTNT-H9-derived cardiomyocytes  
On the basis of their electrophysiological properties, CM can be characterized as atrial-, ventricular- or 
pacemaker-like (He et al., 2003; Mummery et al., 2003). In order to characterize the contracting CM, 
they were measured in the whole-cell configuration of the current clamp technique. Since it was not 
possible to dissociate the cardiac clusters into single cells with trypsin or Accutase®, measurements 
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were performed in normal cTNT-H9 derived-cultures with cells that were at the margin of beating 
clusters. Still, only three cells of control samples could be measured and therefore, no statistically 
significant results were obtained. The characteristics of the measured cells are summarized in Table 9 
and recorded traces of their spontaneous AP are shown in Fig. 32. Maximum diastolic potentials 
(MDP) were around -35 and -23 mV and their AP peaked between 40 and 60 mV.  
In the 4 s-traces (Fig. 32 A), a sharp upstroke is dominant for cell 1 and 2. In the 1 s-traces (Fig. 32 B), 
it becomes apparent that their repolarization first started slowly, then more rapidly. The AP of cell 3 
shows a steady slow depolarization and the upstroke is not as sharp as in cells 1 and 2. 
 
Table 9: Electrophysiological characteristics of three cTNT-H9-derived CM. 
# Cell n (AP) Beat rate (bpm) APA (mV) MDP (mV) 
1 16 96 73.3 -35.2 
2 12 72 84.6 -22.8 
3 15 90 68.8 -22.7 
n (AP), number of AP; MDP, maximum diastolic potential; APA, AP amplitude 
 
 
Fig. 32: Action potentials of three contracting cTNT-H9-derived CM at day 15 of differentiation. 
Spontaneous APs were recorded in the whole-cell configuration of the current clamp technique for several 
seconds using the I0-current. Four seconds (A) and one second (B) traces of each cell are shown. 
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3.6.2 Effect of ivabradine on the beat rates of the cardiac clusters 
Ivabradine is a specific HCN channel blocker. According to Bucchi et al. (2006) its half-block 
concentration is 2 µM for HCN4 and 0.94 µM for HCN1. Therefore, starting from 2 µM, increasing 
concentrations were added to the cardiac cultures at day 15. The beat rates of cardiac clusters derived 
from sham (Fig. 33 A) and 1 Gy-irradiated cTNT-H9 cells (Fig. 33 B) were decreasing starting from 
8 µM. With 40 µM ivabradine, the maximum slowdown was reached and higher concentrations did 
not lead to a further deceleration. 
 
 
Fig. 33: Effect of ivabradine on the beat rates of cTNT-H9-derived cardiac clusters. At day 15 of 
differentiation, increasing concentrations of ivabradine between 2 and 100 µM were tested in cultures derived 
from controls (A, four clusters) and 1 Gy-irradiated cells (B, five clusters). Each color represents one cluster. 
 
3.7 Characterization of the supporting cell layer in cTNT-H9-derived cardiac cultures  
Since also non-cardiac cells developed in the cardiac cultures (Fig. 17) and it is known that endothelial 
cells support CM growth and function (Brutsaert, 2003; Tirziu et al., 2010), endothelial markers, 
namely CD31 and vWF, were analyzed in the cTNT-H9-derived cardiac cultures on the mRNA and 
protein level (Fig. 34).  
CD31 expression appeared at day 5 of differentiation (Fig. 34 A) and increased until day 15. The 1 and 
2 Gy-irradiated samples showed a trend towards decreased levels at day 5, 8 and 15. 
In controls, vWF expression peaked at day 5 and decreased subsequently (Fig. 34 B). At day 5, its 
expression was by tendency decreased in samples derived from 0.1 Gy-irradiated cells. Upon 1 and 2 
Gy exposure, its amount was markedly decreased in six out of seven experiments. However, at day 8 
and 15, vWF expression was comparable to controls upon all tested doses. 
Immunocytochemical analyses verified the expression of CD31 and vWF protein in non-cardiac cells 
at day 5 and 8 (Fig. 34 C, D). At day 5, the majority of the non-cardiac cells were vWF-positive and 
there were more CD31-positive cells compared to day 8. At day 8, the number of vWF- and CD31-
positive cells was lower and especially the CD31-signal was mostly detected in apoptotic cells in 
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controls as well as in irradiated samples, making it difficult to identify specifically positive cells. 
These mostly occurred in small groups (Fig. 34 C). CD31 was not as finely structured as in HDMEC 
(positive control, App. Fig. 18 A) and not distributed around the whole cell. 
 
 
Fig. 34: Expression of CD31 and vWF in cTNT-H9-derived cardiac cultures. A, B) Dose effect-curves of 
qRT-PCR based analyses of CD31 (A) and vWF (B) gene expression at day 5, 8 and 15 of differentiation of 
sham controls, 0.1, 1 and 2 Gy-irradiated cTNT-H9 cells. Values were normalized to 18sRNA and to the highest 
control mRNA level of each target in each experiment. Student’s t-test was performed among experiments; 
* p < 0.05. d, day. C, D) Representative pictures of immunocytochemical analyses of CD31 (C, red) and vWF 
(D, red) in sham controls at day 8. DNA was stained with Hoechst-33342 (blue). Green: cTNT-H9 cells 
expressing GFP as reporter for cTNT-expression; scale bars: 10 µm. 
 
vWF is stored in Weibel-Palade bodies (Valentijn et al., 2014). These structures were also observed in 
the supporting cells of the cTNT-H9-derived cardiac cultures (Fig. 34 D). However, their number per 
cell was lower and their structure was not as pronounced as in HMVEC cells, which were used as 
positive control (App. Fig. 18 B). In two out of five experiments, the cultures derived from 2 Gy-
irradiated cells had a clear increase of vWF-positive cells compared to controls and vWF-positive cells 
occurred mostly in large non-cardiac clusters (not shown). In one of these two experiments, this 
increase was also observed on the mRNA level.  
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In addition to CM and endothelial cells, smooth muscle cells play an important role in the heart in 
vivo, and it was described by Mummery et al. (2003) that in vitro also endodermal cells play a 
synergistic role in cardiac differentiation. Therefore, expression of MYH11, encoding the smooth 
muscle Myosin Heavy Chain 11, and AFP, encoding Alpha Fetoprotein, a marker for definitive 
endoderm, were additionally investigated (App. Fig. 19).  
In general, MYH11 expression level was low and near baseline. Increased CT-values were only 
detected at day 15. However, the magnitude of expression changes was low and no marked overall IR-
induced trend was detected (App. Fig. 19 A). Still, by tendency MYH11 expression was lower in 
samples derived from 0.1 and 1 Gy-irradiated cells. For the 2 Gy samples, the variation was high 
among experiments.  
In contrast, AFP expression appeared at day 5 and peaked at day 15, clearly distinguishable from 
baseline levels. No clear changes were detected between controls and irradiated cultures (App. 
Fig. 19 B). 
 
3.8 Impact of X-ray exposure at specific cardiac differentiation stages  
Since the pluripotent state exists only for a very short time in vivo, it is statistically more likely that the 
embryo is exposed to IR at a later stage of development. Therefore, differentiating cTNT-H9 cells 
were irradiated with 1 Gy at day 5, when cardiac progenitor cells develop, or at day 8, when 
spontaneous beating occurs, in n = 3 independent experiments.  
Spontaneously beating cardiac clusters formed in all conditions and no apparent differences in their 
number was detected. Gene expression determined via qRT-PCR was compared to sham controls at 
until day 29 of differentiation. Fig. 35 depicts the gene expression of the cardiac progenitor marker 
NKX2.5 and three representative cardiac markers (TNNT2, MYH6 and MLC2v) for all three 
experiments. Medians of each target gene showed by trend no alterations caused by irradiation, 
however, depending on the experiment, mRNA levels varied.  
 
It is noteworthy that the cTNT-H9 cells used for these experiments were of higher passages and that 
the resulting cardiac clusters of two out of the three experiments had a different morphology than 
those in the experiments before. As already described for two experiments in section 3.3, the CM 
formed thin layers of GFP-positive cells spanning large parts of the culture dishes rather than round 
compact clusters (App. Fig. 10 A-C). Beat rates of these layers were much higher than in previous 
experiments and exceeded the physiological range (App. Fig. 20 A, B). However, clusters with the 
normal round, compact morphology had beat rates comparable to those derived from cells of earlier 
passages. Since this altered phenotype also appeared in two experiments of section 3.3, it is not a 
result of the irradiation during differentiation. Comparing the CT-values of various differentiation 
markers between experiments with early and late passage cells, revealed no differences (data not 
shown). Hence, only the morphology and beat rates were altered. 
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In the one experiment with cluster morphologies comparable to those of early-passage-experiments, 
no differences were observed between the beat rates of all three conditions (App. Fig. 20 C). In 
addition, in all three experiments clusters of all conditions were able to react to isoproterenol at day 
15, 22 and 29 (data not shown). 
 
 
Fig. 35: Expression of cardiac marker genes after irradiation of the cardiac cultures at day 5 or 8 of 
differentiation. At day 0, differentiation of the cTNT-H9 cells was initiated. Cardiac cultures were irradiated 
with 0 (sham control, black) or 1 Gy X-rays at day 5 (gray) or day 8 (blue) and expression of NKX2.5 (A), 
TNNT2 (B), MYH6 (C) and MLC2v (D) was analyzed until day 29. Values were normalized to 18sRNA and to 
control samples with the highest expression level for each target in each experiment. Data of n = 3 independent 
experiments are shown. Red line, median; d, day. 
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4 Discussion 
 
The human embryo may be exposed to IR due to medical needs of the mother or by nuclear accidents. 
The developmental risks depend on the dose of the in utero exposure and the stage of gestation, with 
the most susceptible stages being the preimplantation phase and organogenesis in the first fifteen 
weeks post conception (Williams and Fletcher, 2010). Since studies on human embryos are ethically 
unjustifiable and infeasible, hESCs are a suitable model system to evaluate the risks of an in utero 
exposure to diverse noxae and to investigate the underlying molecular mechanisms. The heart is a very 
radiosensitive organ and its correct formation during development is crucial for all subsequently 
developing organs to be supplied with oxygen and nutrients. Using specific protocols, hESCs can be 
differentiated into functional CM by recapitulating all stages of early cardiogenesis. Using this model 
system, several noxae, like IR or drugs can be analyzed for possible cardiotoxic effects. In addition, 
hESC-derived CM are of high interest for regenerative medicine, e.g. for the treatment of infarcted 
hearts. Since the medical use of IR, especially X- and γ-rays, is steadily increasing also for pregnant 
women (Chen et al., 2008), a detailed risk assessment for the embryo is crucial and the results of this 
study aim to contribute to it. 
 
4.1 hESC-derived cardiac cultures markedly differ depending on the factors used for differentiation 
In our laboratory, cardiac differentiation of hESCs was previously performed according to the GiWi-
protocol by Lian et al. (2013a). However, differentiation efficiency was low and effects of IR-
exposure were not reproducible (unpublished data). In order to enhance the efficiency, a more recent 
protocol by Kadari et al. (2015) was established.  
 
4.1.1 Cardiac differentiation efficiency of hESCs is enhanced by stage-dependent modulation of WNT 
signaling and a higher proliferation rate 
Compared to the protocol by Lian et al., the one by Kadari et al. led to a higher cardiac differentiation 
efficiency of H9 cells (section 3.1). This was evidenced by higher levels of cardiac marker genes and 
expression of the more mature and ventricular marker MLC2v on gene and protein level. In addition, 
structural organization of α-Actinin and cTNT of the hESC-derived CM was by tendency higher. 
These differences can be attributed to only three substances, namely BMP4, XAV939 and ascorbic 
acid. Supplying the cells with BMP4 in addition to CHIR99021 in the first 24 h of cardiac 
differentiation, additionally supports canonical WNT signaling leading to an earlier onset of MESP1 
expression (day 1, Fig. 11 B).  
As reviewed by Gessert and Kühl (2010), different WNT pathways play crucial roles depending on the 
phase of cardiac differentiation: whereas mesoderm formation depends on canonical signaling, this 
pathway needs to be blocked subsequently for the development of cardiac progenitors. In this phase, 
non-canonical WNT signaling is supportive. Using IWP2 according to Lian et al. (2013a), canonical 
as well as non-canonical WNT signaling are inhibited since palmitoylation of WNT proteins by Porcn 
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is prevented (Chen et al., 2009). In contrast, XAV939 used by Kadari et al. (2015) specifically inhibits 
canonical WNT signaling (Huang et al., 2009), whereas non-canonical signaling can operate to 
enhance CM development. This was evidenced by a higher expression of WNT11, which is involved in 
non-canonical signaling (Mazzotta et al., 2016; Pandur et al., 2002b), in the cardiac cultures resulting 
from the Kadari protocol (App. Fig. 1 D). At the same time, NKX2.5-positive cardiac progenitor cells 
developed and reached higher levels compared to the Lian protocol (Fig. 11 D). The increased levels 
of cardiac progenitor as well as cardiac marker genes with the Kadari protocol can be attributed 
additionally to the ascorbic acid in the differentiation medium, which enhances proliferation of the 
progenitors via the MEK-ERK1/2 pathway (Cao et al., 2012).  
In summary, the higher cardiac differentiation efficiency using the Kadari protocol is due to enhanced 
stage-dependent WNT signaling modulation and probably also due to increased proliferation of the 
cardiac progenitors. However, the latter was not specifically investigated. 
 
Kadari et al. (2015) enhanced CM yield by lactate supplementation. However, in the present study, 
this did not increase the number of CM at day 15 (not shown) and was thus not applied. One possible 
explanation for this is that a high number of supporting non-cardiac cells in the cultures disappeared 
upon replacement of glucose with lactate. This is due to their inability to metabolize lactate, which is 
in contrast to cardiac cells (Tohyama et al., 2013). Without their supporting signals, cardiac 
differentiation was probably hampered so that no new cardiac clusters could develop. 
Furthermore, the differentiation medium used in this study did not contain insulin throughout the 15 
days in contrast to the original protocol by Kadari and colleagues. In the early stages of differentiation, 
insulin has a negative effect on CM development (Freund et al., 2008) that can be rescued by a stage-
dependent modulation of canonical WNT signaling (Lian et al., 2013b). Therefore, no insulin was 
used at the early stages of differentiation. At later stages, no insulin was added in order to keep the 
cells in constant conditions and to avoid negative effects of insulin on slower differentiating cells.  
 
4.1.2 Beat rates of the cardiac clusters varied, but beat variability decreased with the time of culture 
when WNT signaling was modulated precisely 
A first sign of the development of functional CM is the onset of spontaneous contractions. Increasing 
beat rates are linked to an enhanced cardiac output during mouse embryonic development (Keller et 
al., 1996; Moorman et al., 1998) and are also observed in vitro in mESC-derived cardiac EBs (Sauer et 
al., 2001). However, an in vitro study showed decreased beat rates for late hESC-derived CM (26±3 
bpm) compared to early ones (36±6 bpm; Sartiani et al., 2007), which is clearly lower than the normal 
fetal and adult human heart rate. 
In two experiments comparing the protocols by Lian et al. and Kadari et al., video-based analyses of 
the beat rates showed no reproducible protocol-dependent differences since the experiments showed 
contrary trends (Fig. 15). It was reported that differentiation mediated by addition of FCS led to a 
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certain variability in the developing cardiac cell types and markedly varying beat rates (i.e. 38 -
106 bpm; He et al., 2003). Despite the more complex modulation of the signaling pathways in the 
present study, the developing cardiac clusters were still heterogeneous and also the beat rates varied 
markedly, however, in the same range as described by He et al. (2003). For functional analyses of 
hESC-derived CM, it is thus necessary to analyze a high number of cardiac clusters to embrace a 
broad spectrum of the heterogeneous cultures.  
Whereas beat variability remained high for the clusters of the Lian protocol throughout differentiation, 
it was clearly reduced for those generated with the Kadari protocol at day 15. One reason could be 
differing morphologies: the clusters derived from the Kadari protocol were compact and thus, 
“isolated” from each other, allowing an individual development. In contrast, the clusters derived from 
the Lian protocol were strand-like and some were connected with each other. In some cases, these 
strand-like structures became more compact over time losing their interconnectedness. It is possible 
that these changes affected the beating features of the Lian protocol-derived clusters, whereas in those 
of the Kadari protocol only the cell number increased, but the morphology remained the same over 
time. Another reason might be that due to a higher maturation state evidenced by the expression of 
MYH7 mRNA as well as MLC2v mRNA and protein, the Kadari protocol-derived clusters had an 
enhanced intercellular communication leading to a more regular beating. 
 
Cardiac clusters derived from both protocols responded to isoproterenol indicating the presence of 
functional β-adrenergic receptors and HCN channels. The elevated beat rates are the results of the β-
adrenergic receptor-mediated increase of intracellular cAMP levels. This shifts the HCN channel 
opening potential to more positive values, especially that of HCN2 and HCN4 (Biel et al., 2002), 
leading to elevated beat rates.   
 
4.2 Cardiac differentiation is more efficient using a feeder-free culture system 
hESCs are often cultured on a MEF feeder layer with an exogenous FGF2-supply to maintain their 
pluripotency via increased levels of Tgfb1 and Activin A secreted by the MEFs (Greber et al., 2007). 
In the present study, cardiac differentiation of H9 cells grown on MEFs was not efficient and 
reproducible. Using the feeder-free cTNT-H9 cell line, more cardiac clusters developed and 
expression levels of cardiac genes were higher compared to the H9-derived cultures (Fig. 20). A 
possible explanation for the hampered differentiation of H9 cells grown on MEF feeders is that cells 
were transferred to Matrigel®- or Geltrex®-coated culture plates by using cell scrapers. Thus, the 
MEF feeders were still present in the culture and hampered differentiation by their pluripotency 
maintaining signals.  
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4.3 The wildtype H9 and the transgenic cTNT-H9 cell line have a comparable radiation response 
It is well known that ESCs possess unique features to efficiently protect the stem cell pool from 
genetic aberrations and mutations (see section 1.2.2) and culture conditions markedly influence 
genomic stability (Draper et al., 2004; Mitalipova et al., 2005; Nguyen et al., 2013). Luft et al. (2017) 
described that depending on the method of passaging, H9 cells showed a distinct radiation response: 
Manually passaged cells had a higher percentage of aberrant cells and a higher fraction of apoptosis 
24 h after X-ray irradiation compared to enzymatically passaged cells indicating that the manually 
passaged ones are more sensitive to radiation and more efficient in eliminating aberrant cells from the 
culture. In order to establish a model system to study radiation impacts on hESC cardiac 
differentiation, the transgenic cTNT-H9 cells were characterized in terms of their radiation response in 
comparison to the H9 cells. For this reason, karyotypic and cell death analyses were performed. 
 
4.3.1 cTNT-H9 cells are genetically stable and have a comparable fraction of aberrant cells upon X-
ray exposure as the wildtype cell line 
There are few publications using the reporter cell line cTNT-H9 (e.g. Garate et al., 2018; Hazeltine et 
al., 2014; Pallotta et al., 2017). In most of them, the cells were co-cultured with MEF feeders, the 
methods of passaging were not always described in detail and no cytogenetic data were included. In 
the study at hand, several passaging methods were tested for the feeder-free cTNT-H9 cell, but only 
with ReleSR
TM
 a sufficient number of pluripotent colonies was obtained over multiple passages. Since 
cytogenetic analyses of cTNT-H9 cells passaged with ReleSR
TM
 are not available, the karyotype of 
high-passage cells was investigated via mFISH. As described in section 3.2.1, no chromosomal 
aberrations were detected until passage 75 indicating a high efficiency to maintain genetic stability 
within the cell pool.  
One day after exposure to 1 Gy X-rays, the cTNT-H9 cells showed a comparable high fraction of 
aberrant cells as the wildtype H9 cells analyzed by Luft et al. (2017) and seven days after exposure, 
the percentage of aberrant cells was reduced (App. Table 8). These results indicate that irradiated H9 
and cTNT-H9 cells are comparably efficient in removing aberrant cells from the population. 
24 h after irradiation of the cTNT-H9 cells with 2 Gy, hardly any mitotic cells were found. The reason 
for that could be that most cells underwent cell death already within the first 24 h post irradiation and 
only very few cells survived. Therefore, the overall amount of cells was probably too low. 
 
4.3.2 Massive cell death occurs upon IR exposure of cTNT-H9 cells 
A general observation upon irradiation of ESCs is massive cell death (see section 1.2.3). In the present 
study, apoptosis and necrosis were quantified upon exposure of the cTNT-H9 cells to 1 Gy X-rays via 
FACS analyses. By trend, there was a two-fold increase in apoptotic cells at 24 h and 48 h compared 
to sham controls (Fig. 19). 72 h after exposure, the highest number of apoptotic cTNT-H9 cells was 
measured (four-fold increased compared to controls), whereas the fraction of necrosis was two-fold 
   
  - 65 - 
increased compared to controls at all three time points. In a direct comparison (n = 1, data not shown), 
the wildtype H9 cells showed only a 2.1-fold elevated apoptotic fraction at 24, 48 and 72 h post 
irradiation and a high fraction of necrotic cells at 24 and 48 h compared to controls (8.5- and 3.7-fold 
increased, respectively). These results together with those by Luft et al. (2017), who showed an almost 
five-fold increase in apoptosis 24 h after 1 Gy X-ray exposure compared to controls, indicate that the 
wildtype H9 cells eliminate most damaged cells within the first 24 h. In contrast, cTNT-H9 cells 
showed a delayed peak of cell death at 72 h. The reason for this delay could not be clarified yet.  
 
4.4 hESC-derived cardiomyocytes develop functional gap junctions and ion channels 
The basis of spontaneous contractions of cardiac cells is electrical activity (i.e. ion currents), which 
depends on the presence of functional ion channels in the CM and on the propagation of these 
electrical signals between adjacent CM via gap junctions (see section 1.3.2).  
 
4.4.1 Gap junctions connect adjacent hESC-derived cardiomyocytes 
Gap junctions allow the direct communication and propagation of electrical signals between adjacent 
CM (Gros and Jongsma, 1996; Söhl and Willecke, 2004). Cx43 is the most abundant gap junction 
protein in the mammalian heart (Gros and Jongsma, 1996) and involved in the communication 
between pluripotent hESCs (Wong et al., 2008). Immunocytochemistry revealed expression of Cx43 
protein at high levels in the pluripotent hESCs (data not shown). Compared to them, Cx43 was 
expressed at a much lower density in the hESC-derived CM and no difference was detected between 
controls and irradiated cells. In contrast, for CM derived from mESCs exposed to 5 Gy γ-rays a 
decreased density of Cx43 was reported and associated with a reduced beat rate (Rebuzzini et al., 
2013). The discrepancies to the present study may arise from different cells, doses and differentiation 
methods.  
 
4.4.2 β-adrenoreceptors are functional, however, develop with a variable pace and density 
In the heart, β-adrenergic receptors are responsible for an increased contraction force and heart rate 
especially via the hormone adrenaline. Isoproterenol is an agonist of these receptors and leads to an 
increased intracellular level of cAMP. This in turn results in an enhanced calcium release from the SR, 
thereby increasing the contractility of CM. Cardiac clusters derived from hESCs using the Lian and 
Kadari protocol responded to isoproterenol, indicating the presence and functionality of β-adrenergic 
receptors. However, some clusters showed a delayed or no response (App. Fig. 2 and Fig. 27). Still, 
when these clusters were recorded at day 22 and 29, their response was normal (data not shown). A 
possible reason is that not all CM developed with the same pace and thus, some might have a more 
mature phenotype than others. This assumption is supported by a study by Chen et al. (1979) who 
showed that the responsiveness to isoproterenol depends on the age of murine fetal hearts: at an early 
stage, the hearts did not respond even though β-adrenergic receptors were already present, but with 
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ongoing development, the response was more pronounced most likely attributable to a growing 
receptor density. In addition, He et al. (2003) described a 33+/-27 % increased beat rate upon 
isoproterenol, indicating a marked variability among hESC-derived EBs. These results and those of 
the present study point at a varying differentiation pace of the hESC-derived CM. Even with the same 
protocol and in the same petri dish there might be cells with less (and/or less mature) β-adrenergic 
receptors and thus, have a lower chronotropic response to isoproterenol than others at one defined time 
point. For this reason, the CM derived from the 2 Gy-irradiated hESCs are likely to have a more 
immature phenotype and a lower density of β-adrenoreceptors compared to controls (Fig. 27). In a 
previous study, a delayed cardiac differentiation of mESCs upon irradiation was reported (Helm et al., 
2016). Hence, it was analyzed whether the isoproterenol responsiveness of the 2 Gy-irradiated clusters 
reached control levels after a prolonged culture time. However, due to the low amount of surviving 
cells after the 2 Gy irradiation, their cardiac development could only be monitored in two out of five 
experiments until day 29. Yet, in these experiments, their responsiveness did not reach the day 15-
levels of controls (data not shown), suggesting that hESCs are more sensitive to X-ray irradiation than 
mESCs since they keep their immature phenotype for a prolonged time upon a 2 Gy exposure. 
 
4.4.3 HCN4 channels are functional in cTNT-H9-derived cardiac clusters 
One of the three main currents of the cardiac pacemaker, namely the funny current (If), is generated by 
HCN channels and in the adult SAN, HCN4 is the main isoform (Stieber et al., 2003). Compared to 
the SAN, HCN4 expression is downregulated in the working myocardium (Weisbrod et al., 2016). 
Whereas early ventricular myocytes express HCN4 and beat spontaneously, they lose their ability to 
beat with ongoing development and switch to HCN2 expression (Yasui et al., 2001). Furthermore, If 
currents are downregulated in the chambers compared to the conduction system (Abi-Gerges et al., 
2000). Since atrial and ventricular If currents activate with slower kinetics and at lower activation 
potentials than those of the SAN, they do not play a functional role at physiological conditions (Biel et 
al., 2002). Therefore, analyses of HCN4 can give hints regarding the cardiac cell types generated by in 
vitro differentiation of hESCs. 
Even though the presence and functionality of HCN channels was already evidenced by the increased 
beat rates upon addition of isoproterenol, their contribution to the spontaneously beating cardiac 
clusters was further investigated. In line with the results of Sartiani et al. (2007), HCN4 was detected 
on the mRNA level in the pluripotent H9 and cTNT-H9 cells (Fig. 12 D and Fig. 22 B). After 
initiation of differentiation, its gene expression was decreased, but with the onset of spontaneous 
beating, it was elevated again. However, its protein expression was not clearly detected (App. Fig. 8). 
Therefore, the presence of the If current was investigated in the whole-cell configuration of the current 
clamp technique. Since it was impossible to singularize the hESC-derived clusters with trypsin or 
Accutase®, the measurements were hampered in the normal cardiac cultures resulting from the Kadari 
protocol. Only three cells could be measured and thus, the results are not statistically significant. Still, 
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one out of the three measured cells appeared to be pacemaker-like (Fig. 31, cell 3), since the shape of 
its AP showed a steady diastolic depolarization, which is characteristic for the SAN AP (Baruscotti et 
al., 2005; compare section 1.3.2). The AP of the other two cells rather resembled ventricular-like ones 
according to He et al. (2003) and Mummery et al. (2003). The AP amplitudes were in a comparable 
range to the literature, but their maximum diastolic potentials and the AP peaks were shifted to more 
positive values compared to adult CM. This was also observed in other studies and is probably due to 
the immature ion currents in the hESC-derived CM (Keung et al., 2014; Yang et al., 2014).   
To increase the number of measured cells, the conditions need to be improved for future experiments. 
First of all, cardiac clusters should be dissociated into single cells, for example by using collagenase 
(Mummery et al., 2003). Compared to trypsin, this is a much milder reagent preserving the integrity of 
the cell membrane lipids (Kirkpatrick et al., 1985), thereby allowing the reattachment of functional 
CM. In addition, the Port-a-patch system (Nanion Technologies) is a valuable surrogate technique 
since single cells are automatically captured and sealed by suction with a computer-controlled pump, 
thereby increasing the output. 
Furthermore, ivabradine was used in this study to specifically inhibit HCN channels to analyze their 
contribution to the spontaneous contraction of the hESC-derived cardiac clusters. Ivabradine decreases 
the slope of the diastolic depolarization curve, leading to prolonged intervals between two APs and 
thereby, reduces the beat rate (Thollon et al., 1997). Increasing concentrations of ivabradine in the day 
15-cardiac cultures led to decreased beat rates (Fig. 33), indicating the presence of HCN4 and HCN1 
channels. However, between 40 and 100 µM no further slowing down was detected, hinting at 
compensating mechanisms within the clusters. Upon addition of 100 µM ivabradine, Niehoff et al. 
(2016) detected a reduction to 45 % of the initial beat rate of mESC-derived cardiac EBs. In contrast, 
the beat rate was reduced to about 27 % in the present study suggesting that the hESC-derived CM are 
more sensitive to this drug than mESCs.  
 
All these results indicate that pacemaker-like cells are present in the hESC-derived cardiac clusters. 
They might, however, not all express HCN4, since a distinct HCN4 signal was only detected in some 
clusters, and like in the adult heart, their number is lower compared to atrial and ventricular CM.  
 
4.5 Cardiac differentiation of hESCs is impaired by IR 
Studies of atomic bomb survivors that were exposed to radiation in utero, revealed no significantly 
increased number of cardiovascular disease cases up to now compared to an unexposed control group 
and controversial results were reported for their risk of hypertension (Tatsukawa et al., 2008). 
However, exposure of adults leads to an increased risk for cardiovascular diseases in atomic bomb 
survivors and breast cancer patients (see section 1.3.4, Puukila et al., 2017; Taylor and Kirby, 2015). 
Up to date, there are only few studies dealing directly with the influence of a radiation exposure of 
ESCs on cardiac differentiation (Helm et al., 2016; Rebuzzini et al., 2013) reporting that gene 
expression of differentiating mESC-derived CM and their functionality are impaired. The present 
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study provides additional information that cardiac differentiation also of hESCs is impaired by an X-
ray exposure. During differentiation of the hESCs, also non-cardiac cell types developed that typically 
co-exist and support each other in the living heart (Fig. 34 and App. Fig. 19), resulting in a suitable in 
vitro model system for studying cardiotoxic effects. qRT-PCR arrays were performed with irradiated 
hESCs to shed light on possibly altered molecular mechanisms that could influence differentiation. 
However, for these arrays, samples before initiation of differentiation were used and each array was 
performed only once for each time point. Therefore, no statistical significance was achieved and the 
results only served to gain a first impression of IR-induced alterations in gene expression of 
pluripotent hESCs. 
 
Exposure of the cTNT-H9 cells to IR did not markedly affect expression of pluripotency markers, 
namely OCT4 and NANOG, neither on mRNA nor on protein level. Upon initiation of differentiation, 
also mesoderm formation indicated by T expression was not impaired by all tested doses (Fig. 21) and 
in line with this, NOTCH1 expression, which was described to negatively impact on mesodermal 
differentiation (Schroeder et al., 2006; Nemir et al., 2006), did not differ from controls (App. 
Fig. 12 C).  
Following this stage of differentiation, cardiac mesoderm is formed, which is marked by MESP1, one 
of the key regulators of cardiac development (Bondue et al., 2008; Islas et al., 2012; Saga et al., 2000). 
Whereas 0.1 Gy did not have a general effect on its expression, it was clearly reduced following the 1 
and 2 Gy exposure indicating an impaired cardiac mesoderm formation. Possible underlying 
mechanisms could not be identified in this study. MESP1 is regulated among others by Brachyury 
(David et al., 2011) and SP1 (Beketaev et al., 2016) . However, since no IR-induced alterations in their 
gene expression were found, other mechanisms must be responsible for MESP1 downregulation. One 
possible candidate revealed by the qRT-PCR arrays is LEF1. Binding of Oct4 and Tcf/Lef to the 
Mesp1 promoter leads to its expression in differentiating mESCs (Li et al., 2013). In the present study, 
LEF1 expression was increased in the first days of differentiation of the 2 Gy-irradiated cells 
compared to controls. This hints at dysregulated gene expression that could lead to carcinogenesis 
since high levels of LEF1 are associated with leukemia (Metzeler et al., 2012). In combination with 
upregulated active β-catenin, it leads to elevated expression of target genes of canonical WNT 
signaling. Indeed, according to the results of the SCS-array, also CTNNB1 (encoding β-catenin) was 
upregulated. However, whether LEF1 and β-catenin are also increased on the protein level remains to 
be investigated. 
NKX2.5, a marker of cardiac precursor cells, was dose-dependently decreased (Fig. 22 A). It was 
suggested to be one of the earliest targets of FGFR1 (Dell’Era et al., 2003). However, since no IR-
induced alterations in FGFR1 expression were detected, this pathway does not seem to be impaired 
upon an exposure of the hESCs. In mouse cells, Nkx2.5, Tbx5 and Gata4 were found to be direct 
targets of Stat3 (Snyder et al., 2010). Glycoprotein-130 (gp130) is a receptor, which is encoded by the 
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gene IL6ST and is upstream of STAT3-signaling involved in cardiac development (Fischer and 
Hilfiker-Kleiner, 2008). In the differentiating cardiac cultures derived from irradiated cTNT-H9 cells, 
IL6ST expression was reduced compared to controls (Fig. 28) suggesting that CM formation is 
impaired due to impaired gp130/ STAT3 signaling. This should be investigated in more detail and on 
the protein level in future studies.  
 
All subsequently emerging cardiac marker genes (e.g. TNNT2, MYH6/7, MLC2a/v) were likewise 
dose-dependently decreased (Fig. 22 and Fig. 23). Possible reasons are the reduced amount of 
NKX2.5-positive cardiac precursor cells and the reduction of WNT11 (Fig. 30 A). The supportive 
function of WNT11-mediated non-canonical WNT signaling in differentiation of cardiac progenitors 
was described by Mazzotta et al. (2016; see Fig. 4). These results suggest that cardiac differentiation is 
hampered upon irradiation by impaired WNT-11 mediated non-canonical WNT signaling, whereas the 
WNT5B mediated non-canonical signaling, which is more important in early differentiation steps, was 
not affected (Fig. 30 B). However, this requires further verification on the protein level.  
Additionally, miR-1 is expressed in cardiac muscle and its overexpression in murine cardiac 
progenitor cells has a negative impact on their proliferation (Zhao et al., 2005). The same authors 
showed that miR-1 functions in cardiac progenitor cells, is involved in ventricular development and 
targets Hand2, which is a central cardiac transcription factor involved in myocyte expansion. In 
addition, miR-1 is involved in cardiac cell cycle regulation (Zhao et al., 2007). miR-1 first appeared at 
day 8 and was markedly expressed at day 15 of differentiation (Fig. 31). In three out of six 
experiments, its expression was decreased upon irradiation with all three doses. However, in the other 
three experiments, a reduction was only detected in the 1 Gy samples, but following the 0.1 and 2 Gy 
exposure, miR-1 was several fold increased compared to controls (Fig. 31). Despite these unexpected 
results, which cannot be explained at the moment, irradiation seems to reduce miR-1 expression. Since 
Hand2 is among its downstream targets, CM expansion might be affected leading to a lower amount of 
CM and thus, to lower levels of cardiac genes. 
On the protein level, MLC2v expression and structural organization was impaired following the 2 Gy 
exposure (Fig. 24) and CM functionality (beat rates and response to isoproterenol) was affected (see 
sections 3.3.3 and 3.3.4) suggesting an even more immature phenotype than the control CM (discussed 
in section 4.4.2). In contrast to the study by Rebuzzini et al. (2013) who described a decreased beat 
rate of mESC-derived CM following a 5 Gy γ-ray exposure, the CM derived from 2 Gy-irradiated 
hESCs of the present study were rather beating faster than controls.  
Furthermore, NOTCH1 expression was increased at day 15 in the cardiac cultures derived from 2 Gy-
irradiated cTNT-H9 cells. According to Kwon et al. (2009) cardiac progenitor cells exit from 
expansion into the differentiation state via NOTCH1 signaling suggesting that differentiation of the 
progenitor cells derived from 2 Gy-irradiated hESCs is delayed. This assumption is further supported 
by an increased number of very small, newly developed cardiac clusters at day 15 in current 
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experiments (data not shown) and also Helm et al. (2016) reported a delayed cardiac differentiation of 
irradiated mESCs.  
Analysis of the GFP-positive CM separated from non-cardiac cells by Fluorescence-Activated Cell 
Sorting (FACS) would give information on the mechanisms underlying the IR-induced impairment of 
cardiac differentiation. However, sorting the cells was not successful (data not shown) since only a 
very low cell number remained afterwards even though cardiac cultures of day 29 with a high GFP-
intensity were used. For this reason, the question remains whether the observed effects are due to a 
lower number of developing CM or due to altered (lower) cardiac gene expression within the CM. 
 
To verify the results on RNA-level, quantitative protein analyses should be performed in future 
experiments. Currently, samples are prepared for proteomic analyses in collaboration with the 
Helmholtz Centre Munich. Preliminary results (n = 1) suggest that cardiac cultures derived from 1 Gy-
irradiated hESCs have impaired metabolism, enhanced ROS production and alterations in energy 
production pathways, among others.  
 
The results of the DDR- as well as SCS-array were mostly not confirmed by individual qRT-PCR of 
several genes. For example, an upregulation of ATM and CDKN1A (encoding p21) was detected seven 
days post irradiation via the DDR-array with pooled samples. When these were analyzed individually 
for these two genes, no upregulation was detected at that time point. The reason for the apparent 
discrepancy between the array results and those of individual qRT-PCR is not clear. One possible 
reason is the use of different primer sequences leading to amplification of unspecific target genes in 
either the arrays or the individual qRT-PCR. Another reason might be outliers in the pooled samples 
that tamper with the array-results. Mechanical problems were excluded. 
However, it should be mentioned that ATM and p21 were also analyzed on the protein level and both 
were not detected. This is in line with previous studies that did not find an increase of un-
phosphorylated ATM upon DNA damaging treatments (Momcilovic et al., 2009, Mujoo et al., 2017) 
and of p21, which is due to microRNA-mediated degradation of its RNA (Dolezalova et al., 2012). 
This suggests that there was rather a problem with the arrays than with the individual qRT-PCRs. 
 
Nevertheless, the results of the SCS-array revealed many development-associated signaling pathways 
to be affected by an X-ray exposure. The results of the 24 h samples mainly confirm those published 
by Luft et al. (2017) who used the same array with samples of irradiated H9 cells. The authors 
reported further a reduced expression of ACVR1B and ACVR2B in manually passaged H9 cells (1.7-
fold) four days after irradiation with 1 Gy X-rays. This low magnitude decrease was confirmed with 
the individual qRT-PCR of the present study since both genes were decreased (2.0- and 3.0-fold) in 
two out of six samples seven days after irradiation. However, in contrast, the results of the SCS-array 
revealed an upregulation of both genes. It has to be mentioned that only low ACVR1B levels were 
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detected in the cTNT-H9 cells (controls and irradiated samples) in the present study as well as in the 
study by Luft and colleagues. In contrast, ACVR2B was clearly expressed. In the present study, 
expression changes among the individual samples were nearly identical for ACVR1B and ACVR2B, 
which is due to almost unchanged CT-values for all samples. The alterations upon normalization were 
almost exclusively due to changes in 18sRNA levels. Since activin signaling plays an important role in 
cardiac mesoderm formation (Kattman et al., 2011), future studies should address the role of these two 
activin receptor genes in cardiac differentiation upon irradiation.  
 
4.6 High passage cTNT-H9 cells were culture-adapted 
At early passages, cTNT-H9 cells were split 1:5 to 1:8 to allow passage once a week. However, 
around passage 70, the cells started to grow faster and more robustly, thus higher splitting ratios (up to 
1:15) were needed to keep the normal passaging rhythm. The same phenomenon was described by 
Baker et al. (2007) who used H1, H7 and H14 hESCs grown on MEF feeders and reported that at later 
passages, “cells grew more robustly and were split at 1:5 to 1:10 split ratios”, whereas early passage 
cells were split 1:2 or 1:3. The authors assumed that there was an adaptation to the culture conditions 
by mutations or selection. In the present study, the cTNT-H9 cells were analyzed for karyotypic 
abnormalities via mFISH, but also at the highest passage used for this study (p75) no aberrations were 
found (see sections 3.2.1 and 4.3.1). Still, mutations of single genes, which may lead to a selection 
advantage, cannot be ruled out. Genome analyses were, however, beyond the scope of this study. 
 
Cardiac differentiation with higher passage cTNT-H9 cells led to an altered cluster morphology: 
Whereas at day 8 the clusters were small and separated and their beat rates were in a physiological 
range, they showed a higher degree of interconnectedness starting from day 10 and some of them were 
beating very quickly (exceeding 300 bpm). However, beat rates of clusters with the normal round, 
compact morphology were in a physiological range. The thinner the clusters, the higher was their beat 
rate. Altogether, this altered morphology was observed in four out of five experiments using high 
passage cells. An altered differentiation efficiency between early and late passage cells was excluded 
by comparing the CT-values of several differentiation markers among the respective experiments (data 
not shown), indicating that only the cluster-morphology and beat rates were altered. Anyway, it is 
reasonable to re-investigate the impact of an IR exposure at specific differentiation stages with early 
passage cells. 
 
4.7 Exposure to IR at specific stages of differentiation does not markedly impair further cardiac 
development 
Cardiac cultures were exposed to IR at day 5 or 8. At day 5, there should be predominantly cardiac 
progenitor cells, which are still dividing and expanding, and at day 8, when spontaneous beating 
established, it is possible that a certain number of the developing CM already stopped cell cycling. 
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Irradiation at these days did not lead to marked overall alterations in cardiac gene expression and CM 
functionality until day 29. In a previous study, no altered beat rates of primary chicken CM were 
observed upon 0.5 and 1 Gy X-rays (Frieß et al., 2015). Similarly, Heselich et al. (2018) did not 
observe altered beat rates upon titanium or carbon ion irradiation of primary chicken CM especially 
with low doses suggesting a high functional robustness of CM against radiation. In addition, in vitro-
cultured primary beating rat CM were irradiated with very high γ-ray doses (Lampidis et al., 1975), 
showing that below 100 Gy (10,000 rad) neither beat rate nor beating rhythmicity were affected, 
suggesting that post-mitotic cells are radio-resistant. This confirms the results of the present study, 
which further suggest that also cardiac progenitor cells (day 5 hESC-derived CM) do not show 
immediate effects upon IR exposure. 
However, these results do not exclude radiation-induced long-term effects on the CM and their 
functionality. The heart is considered to be a late-responding organ (Boerma et al., 2016) probably due 
to the post-mitotic state of the CM. This is in line with the observation that upon radiotherapy, breast 
cancer patients rarely show immediate cardiac effects, but have a higher risk of cardiovascular 
diseases years or decades after radiotherapy (Boerma et al., 2016). The same observation was made for 
atomic bomb survivors. For this purpose, long-term in vitro studies are needed to investigate the 
molecular mechanisms of these late effects. 
 
4.8 Conclusions and outlook 
hESCs show massive cell death as a first reaction to X-ray exposure in order to eliminate damaged 
cells from the population. The surviving cells continue to express pluripotency markers on the gene 
and protein level. They were differentiated into CM under optimized culture and differentiation 
conditions, which have a great impact on differentiation efficiency. Whereas mesoderm formation was 
not affected by the exposure, a decreased expression of MESP1 indicating impaired cardiac mesoderm 
formation was detected upon the 1 and 2 Gy exposure. Markers of the following differentiation stages, 
comprising precursor cells as well as CM, showed a dose-dependent decrease. Even an exposure to the 
lowest dose tested (0.1 Gy) impaired gene expression, which was even more pronounced upon 1 and 
2 Gy. Effects on the protein and functional level were only detected upon a high dose (2 Gy). This 
suggests that these CM were more immature than those resulting from control hESCs and as 
evidenced by a lower response to isoproterenol even upon prolonged culture time (day 29), they seem 
to keep their immature phenotype and do not reach the maturity level of day 15-control CM. Pathway 
analyses did not yet clarify the mechanisms underlying the impaired cardiac mesoderm differentiation. 
However, data obtained so far indicate that the specification of the cardiac progenitors is hampered by 
impaired miR-1, WNT11-mediated non-canonical WNT and gp130-mediated STAT3 signaling.  
 
In addition, it was shown in three experiments that an exposure to 1 Gy at the cardiac progenitor-stage 
and during the onset of spontaneous beating has no general effect on cardiac gene expression as well 
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as on the functionality of the CM until day 29. These experiments should be repeated with low passage 
hESCs and cardiac cultures should be observed for a prolonged time to investigate the mechanisms of 
possible long-term effects. Furthermore, the impact of irradiation at an earlier time point (e.g. during 
mesoderm formation at day 1 or 2 of differentiation), as well as a radiation impact on the maturation 
capability of the hESC-derived CM needs to be investigated in future. 
 
According to the DGMP- and DRG-report (2002), 0.1 Gy sparsely IR is the threshold dose of an in 
utero exposure, above which the risk for malformations and mental retardation is increased. In the 
present study, 0.1 Gy exposure led to alterations on the molecular level during cardiac differentiation, 
but with high standard errors and CM functionality was not affected. Functional effects only occurred 
after exposure to a high dose. In combination with a study of atomic bomb survivors exposed in utero 
showing no increased numbers of non-fatal cardiac diseases so far (Tatsukawa et al., 2008), these 
results suggest that the risk of cardiac effects upon an in utero exposure to doses below 0.1 Gy, which 
are typically used in medical diagnostics, is negligible. However, higher doses might lead to severe 
effects due to dysregulated developmental processes. hESC-derived cardiac cultures are thus a suitable 
model system to evaluate the risk of an in utero IR-exposure, also because the typical cell types that 
co-exist in the heart in vivo develop during differentiation, thereby mimicking the heart as closely as 
possible. However, this model system might not be sensitive enough to study effects of even lower 
doses since already the results of the 0.1 Gy exposure showed high standard errors. For this, a more 
sensitive approach should be selected, for example on the basis of single cells. In addition, to verify 
the observations of this study protein analyses are needed. Furthermore, various cardiac ion channels, 
especially those involved in calcium fluxes leading to the cardiac contraction should be investigated 
since they are crucial for the correct functionality of CM. 
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Appendix 
 
App. Table 1: Kits. 
Kit Manufacturer Catalog number 
24xCyte Human Multicolor FISH Probe Kit Metasystems D-0125060 
CellEvent
TM
 Caspase-3/7 Green Flow Cytometry 
Assay Kit 
Invitrogen/Thermo 
Fisher Scientific 
C10427 
HOT FIREPol® EvaGreen® qPCR Mix Plus Solis Biodyne                                 083600001 
miScript II RT Kit  QIAGEN 218161 
miScript SYBR Green PCR Kit QIAGEN 218075 
RevertAid RT Reverse Transcription Kit Thermo Scientific K1691 
RNase-free DNase Set QIAGEN 79254 
RNeasy Mini Kit QIAGEN 74106 
RT² First Strand Kit
 
QIAGEN 330404 
RT² SYBR® Green ROX qPCR Mastermix QIAGEN 330523 
 
App. Table 2: Media and supplements 
Substance Source Catalog number 
Ascorbic Acid Sigma Aldrich/Merck A-4034 
B-27
TM
 minus insulin Life technologies A18956-01 
FGF2 PeproTech 100-18B 
β-Mercaptoethanol Carl Roth 4227.3 
BMP-4 PeproTech 120-05 
CHIR99021 BioVision 1991-1 
DMEM Biochrom FG0445 
FCS Biochrom/Merck S0115 
IWP2 Tocris Bioscience 3533 
Knockout DMEM Invitrogen 10829-018 
Knockout Serum Replacer Invitrogen 10828-028 
L-Alanyl-L-Glutamine Merck K0302 
mTeSR1
TM
 Medium STEMCELL Technologies 85851 
mTeSR1
TM
 5x supplement STEMCELL Technologies 85852 
Non-essential amino acids Biochrom/Merck K0293 
Penicillin/Streptomycin Biochrom/Merck A2212 
RPMI 1640 (with stable glutamine) Biochrom/Merck FG1215 
StemBeads® FGF2 StemCultures SB500 
XAV 939 Tocris Bioscience 3748 
Y-27632 ROCK-Inhibitor Enzo Life Sciences ALX-270-333 
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App. Table 3: Chemicals 
Substance Source Catalog number 
Accutase® Life Technologies A11105-01 
Acetic Acid Carl Roth 3738.4 
β-Mercaptoethanol Carl Roth 4227.3 
BSA (Albumin Fraction V) Carl Roth 8076.3 
Chloroform Carl Roth 6340.1 
Citric Acid Monohydrate Carl Roth 5110.1 
Colcemide Biochrom/Merck L6231 
DMSO Carl Roth A994.1 
Ethanol (> 99.8 %) Carl Roth 9065.3 
Fluorescent Mounting Medium Dako S3023 
Formaldehyde (37 %) Carl Roth CP10-1 
Gelatine powder NeoLab 9475.0500 
Geltrex
TM
 Life Technologies A15696-01 
Hoechst-33342 Thermo Scientific 62249 
5x HOT FIREPol® Solis Biodyne 083600001 
Isoproterenol hydrochloride Sigma Aldrich/Merck I6504 
Ivabradine hydrochloride Sigma Aldrich/Merck SML0281 
Laminin-521 BioLamina 600962 
Matrigel Corning 354234 
Methanol Carl Roth 8388.5 
Nuclease free water Acros Organics HV-88295-49 
PBS
-/-
 Merck L1825 
PBS
+/+
 Life Technologies 14040091 
QIAzol® Lysis Reagent QIAGEN 79306 
ReleSR
TM
 STEMCELL Technologies 05872 
Triton X-100 Sigma Aldrich/Merck T8787 
Trypsin PAN-Biotech P10-027500 
 
App. Table 4: Devices. 
Type Manufacturer 
Axio Imager Z2 microscope Zeiss 
Automatic Cell Counter TC20 BioRad 
Dry Bath Incubator FB15103 Thermo Fisher Scientific 
Leica DMI 4000B microscope Leica 
Leica DM IRBE microscope Leica 
Nanophotometer Colibri Titertek Berthold 
PCR Thermal Cycler Peqstar Peqlab/VWR 
Quant Studio 3 Thermo Fisher Scientific 
SN4 dosimeter PTW 
StepOnePlus Real-Time PCR Systems Thermo Fisher Scientific 
UI-3140CP-M-GL Rev. 2 camera IDS 
X-ray Tube Isovolt DS1 Seifert 
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App. Table 5: Softwares. 
Name Manufacturer 
ABI StepOne Software v2.3 ABI/Thermo Fisher Scientific 
cardiac Beat Rate Analyzer (cBRA) F. Braun/M. Scholz 
FACSDiva v7.0 BD Biosciences 
Fiji Open source, contributors: 
https://imagej.net/Contributors 
ISIS Software MetaSystems 
Metafer 4 Software MetaSystems 
Origin OriginLab 
Quant Studio
TM
 Design & Analysis Software v1.4 ABI/Thermo Fisher Scientific 
 
App. Table 6: RNA used for standard curves for different markers. 
Primers RNA used for Standard Curve Manufacturer 
cardiac markers total RNA of human fetal heart tissue 
total RNA of human adult heart tissue 
Clontech 
BioChain 
endothelial markers total RNA of human adult lung tissue BioChain 
endodermal markers total RNA of human fetal liver Clontech 
pluripotency markers pluripotent hESCs - 
mesodermal markers differentiating hESCs at day 2 of cardiac differentiation - 
 
App. Table 7: qRT-PCR-primers for human target genes. All primers were manufactured by the 
company biomers.net. 
Target Sequence (5‘ … 3‘) 
18sRNA (s) ACT CAA CAC GGG AAA CCT CAC C 
18sRNA (as) CGC TCC ACC AAC TAA GAA CGG 
NANOG (s) AAA TCT AAG AGG TGG CAG AAA AAC A 
NANOG (as) CTT CTG CGT CAC ACC ATT GC 
OCT4 (s) ACC CAC ACT GCA GCA GAT CA 
OCT4 (as) CAC ACT CGG ACC ACA TCC TTC T 
Brachyury (T) (s) TGC TGC AAT CCC ATG ACA 
Brachyury (T) (as) CGT TGC TCA CAG ACC ACA 
MESP1 (s) TGA GGA GCC CAA GTG ACA AG 
MESP1 (as) GTC TGC CAA GGA ACC ACT TC 
HCN4 (s) TGA TGG TGG GAA ACC TGA TTA 
HCN4 (as) GTT GAG GAC CAA GTC GAT GAG 
alpha MHC (s) GAC TGT TGT GGC CCT GTA CCA 
alpha MHC (as) TTT TAC CAC TGC CCC AGT ATC G 
beta MHC (s) CTG CAC AGG GAA AAT CTG AAC A 
beta MHC (as) GTC CAT CAC CCC TGG AGA CTT 
MLC2a (s) CTG AGT GCC TTC CGC ATG T 
MLC2a (as) CCA CCT CAG CTG GAG AGA ACT T 
MLC2v (s) CTC TGT CCC TAC CTT GTC TGT TAG C 
MLC2v (as) GCC ACC CAG GCT GCA A 
NKX2.5 (s) CCT GCG GAG ACC TAG GAA CTT 
NKX2.5 (as) CTC ATT GCA CGC TGC ATA ATC 
GATA4 (s) CCT GAA GCT CTC CCC ACA AG 
GATA4 (as) CCA AGA CCA GGC TGT TCC AA 
TNNT2 (s) AGT TCA AGC AGC AGA AAT ATG AGA TC 
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TNNT2 (as) GTG AAG GAG GCC AGG CTC TA 
TBX5 (s) GAA CCA CAA GAT CAC GCA ATT A  
TBX5 (as) ACA CCA TTC TCA CAC TGG TAT  
NPPA (s) TGA TCG ATC TGC CCT CCT A 
NPPA (as) TGT CCT CCC TGG CTG TTA TC 
NR2F2 (s) GCC CGG GTA GCG ACA AG 
NR2F2 (as) CAC GTG AAC TGG CCG TAG TG 
KCNA5 (s) TAC CAC CGG GAA ACG GAT CA 
KCNA5 (as) CTT CGG GCA CTG TCT GCA TT 
CD31 (s) TGC CGT GGA AAG CAG ATA CTC 
CD31 (as) AGC CTG AGG AAT TGC TGT GTT 
vWF (s) TGT CCA GCA GCT GAG TTT CC 
vWF (as) AAG GGT CCC TGG CAA AAT GA 
IRX4 (s) CTC TGG GCC AGT ACC CCT AT 
IRX4 (as) GAG AGG TCC AGG CCA ATT CC 
IL6ST (s) ACT GGA GTG ACT GGA GTG AAG 
IL6ST (as) AGC CTT GAG TAT GGG ATG GA 
WNT11 (s) AGC GCT ATG TCT GCA AGT GA 
WNT11 (as) CCT GGT GGC TTC CAA GTG AA 
AFP (s) CTG CAA ACT GAC CAC GCT 
AFP (as) TGA GAC AGC AAG CTG AGG AT 
MYH11 (s) AGC CGG GAA AAC CGA AAA CA 
MYH11 (as) GCT CTC CGT AGG CAA AAG ATG 
 
App. Table 8: mFISH-based cytogenetic analyses of cTNT-H9 after exposure to 1 or 2 Gy X-rays. 
 
 
analyzed 
cells 
aberrant 
cells 
breaks per 
100 cells 
translocations 
per 100 cells 
dic. per 100 
cells 
complex aberr. 
per 100 cells 
other aberr. 
per 100 cells 
24 h after 
1 Gy 
95 15 9.5 5.3 1 0 2.1 
7 d after  
1 Gy 
183 6 3.8 0.5 0 0 0 
7 d after  
2 Gy 
57 4 3.5 1.75 0 1.75 0 
dic. = dicentric chromosomes; aberr. = aberrations 
 
App. Table 9: Fraction of necrotic cTNT-H9 cells at 24, 48 and 72 h after exposure to 1 Gy X-rays. 
Experiment # 24 h (%) 48 h (%) 72 h (%) 
1 2,21 1,23 1,65 
2 1,80 1,45 1,64 
3 1,02 1,47 2,02 
mean 1,68 1,39 1,77 
 
App. Table 10: Fraction of apoptotic cTNT-H9 cells at 24, 48 and 72 h after exposure to 1 Gy X-rays. 
Experiment # 24 h (%) 48 h (%) 72 h (%) 
1 2,15 2,64 6,03 
2 3,62 1,12 1,72 
3 1,97 2,64 4,18 
mean 2,58 2,13 3,98 
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App. Table 11: Intensity measurement in average-intensity projections of ATM protein in cTNT-H9 
seven days after exposure to 0 and 1 Gy X-rays with the Fiji-Software.  
 
Control 1 Gy 
1 78,81 97,38 
2 91,77 104,48 
3 81,60 81,68 
4 90,78 100,05 
5 81,25 
 
68,04 
6 97,44 
 
123,86 
7 73,04 100,94 
8 97,38 87,99 
9 96,61 77,12 
10 69,78 85,31 
11 81,66 91,92 
12 90,47 76,85 
13 77,35 86,37 
14 87,03 79,81 
15 72,54 
 
102,01 
16 69,29 101,34 
17 84,35 103,43 
18 73,81 90,75 
19 76,82 80,15 
20 97,79 74,46 
Median 81,6 89,4 
Mean 83,5 90,7 
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App. Fig. 1: Marker gene expression during cardiac differentiation of H9 wildtype cells according to Lian 
et al., 2013a (red) and Kadari et al., 2015 (green). At various days during differentiation of H9 cells (black), 
RNA samples were analyzed for the expression of pluripotency genes (A, B), ISL1 (C), WNT11 (D) and atrial 
markers (E, F). Values were normalized to 18sRNA and to the highest mRNA level of each target. WNT11 was 
analyzed in only n = 3 independent experiments. d, day. 
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App. Fig. 2: Increased beat rates of cardiac clusters derived from the Lian et al. and Kadari et al. protocol 
upon addition of isoproterenol. Data of one experiment with two recorded clusters per protocol at day 15 of 
cardiac differentiation before (black) and after addition of 1 µM isoproterenol (gray). 
 
 
App. Fig. 3: Beat rates of H9- and cTNT-H9-derived cardiac clusters. Videos of at least 20 clusters were 
recorded at day 8, 11 and 15 of differentiation for H9 wildtype (black boxes) and cTNT-H9 (green boxes) cells 
of n = 3 independent experiments. Beat rates were determined with the software cBRA.  
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App. Fig. 4: Gene expression analyses of differentiating H9 cells upon exposure to 1 Gy X-rays. T (A), 
NKX2.5 (B), TNNT2 (C) and MLC2v (D) expression was reduced in irradiated samples (blue) compared to 
controls (red). Student’s t-test was performed among experiments. ** p < 0.01; *** p < 0.001; d, day. Black 
symbols, target gene expression in H9 cells before irradiation. 
 
 
App. Fig. 5: Decreased colony size of cTNT-H9 cells upon exposure to 2 Gy X-rays. A) 24 h after irradiation 
with 2 Gy X-rays, the number of dying cells was very high (round, floating cells) and the colonies of the 
surviving cells were very small (red arrows) compared to sham control (B). Scale bar: 100 µm. 
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App. Fig. 6: qRT-PCR based analyses of pluripotency and early cardiac marker genes in irradiated 
differentiating cTNT-H9 cells. The cells were irradiated with 0 (control, black), 0.1 (gray), 1 (green) or 2 Gy 
(red) X-rays at day -7 and cardiac differentiation was initiated at day 0. RNA samples were taken at the indicated 
time points and analyzed for POU5F1 (A), NANOG (B), T (C), MESP1 (D), NKX2.5 (E) and HCN4 (F) 
expression. Student’s t-test was performed among experiments, * p < 0.05; ** p < 0.01; *** p < 0.001. Blue 
symbols, expression levels in pluripotent cells before irradiation; violet line, median; d, day.  
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App. Fig. 7: Cardiac marker gene expression of differentiating cTNT-H9 cells exposed to various X-ray 
doses. Pluripotent cells (blue) were irradiated with 0 (control; black), 0.1 (gray), 1 (green) or 2 Gy (red) and 
seven days later, cardiac differentiation was initiated. RNA samples were collected at several days and analyzed 
for TNNT2 (A), MYH6 (B), MLC2a (C), NPPA (D), MYH7 (E) and MLC2v (F) expression via qRT-PCR. 
Student’s t-test was performed among experiments, * p < 0.05; ** p < 0.01; *** p < 0.001. Violet line, median; 
d, day. 
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App. Fig. 8: Immunocytochemical detection of HCN4 in cTNT-H9-derived cardiac cultures at day 15. Top: 
non-GFP cells showing a weak signal in the red (HCN4) channel. Middle: Some cells near GFP-positive clusters 
had a higher signal in the HCN4 channel. Bottom: HCN4-positive cell with a distinct morphology and no GFP-
expression. DNA was stained with Hoechst-33342 (blue). Scale bars: 10 µm. 
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App. Fig. 9: HEK-293 cells transfected with human HCN4 as positive controls for detection of HCN4. 
Transfected cells were kindly provided by Paolo Zuccholini/Technical University of Darmstadt. HEK293-cells 
were transfected with plasmids containing the hHCN4 gene and a GFP-reporter gene (green). Fixed cells were 
stained for HCN4 (red). DNA was stained with Hoechst-33342 (blue). Scale bar: 20 µm. 
 
 
App. Fig. 10: Altered morphology of the cardiac clusters derived from high-passage cTNT-H9. Thin, 
green-fluorescing layers of contracting CM formed starting from day 10 of differentiation in samples derived 
from sham controls (A), 1 Gy (C) and 2 Gy (C) X-ray irradiated cTNT-H9. Clusters derived from 0.1 Gy 
irradiated cTNT-H9 had the usually observed compact, round morphology (D), however, only few cardiac 
clusters had formed in this sample. 
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App. Fig. 11: Scatter plots of gene expression changes in Stem Cell Signaling upon exposure of cTNT-H9 
cells to 1 Gy X-rays. RNA-samples of sham and 1 Gy X-ray irradiated cTNT-H9 cells were collected at 1 h (A), 
6 h (B), 24 h (C) and 7 d (D) after exposure (n = 6 independent experiments). Samples were pooled for each time 
point and compared to controls using the ΔΔCT-method. All controls were set as one control group 
automatically. For normalization, GAPDH, HPRT1, RPLP0 were used. Results are depicted in scatter plots with 
significantly (more than 2-fold) up- (red) or downregulated (green) genes. Genes whose expression is not altered 
compared to controls (less than 2-fold), are depicted with black dots.  
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App. Fig. 12: Expression of FGFR1, LEF1, NOTCH1 and SP1 during cardiac differentiation of irradiated 
cTNT-H9 cells. Cells were irradiated with 0 Gy (sham control, black), 0.1 Gy (gray), 1 Gy (green) and 2 Gy 
(red) X-rays and cardiac differentiation was initiated seven days later. Expression of FGFR1 was analyzed in n = 
4 experiments (A), LEF1 (B), NOTCH1 (C) and SP1 (D) was analyzed in n = 7 experiments via qRT-PCR. 
Values were normalized to 18sRNA and to the control samples with the highest expression level of each gene. 
The violet line represents the median. Student’s t-test was performed among experiments; * p < 0.05; d, day 
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App. Fig. 13: qRT-PCR based analyses of the expression of activin receptors in the samples that were 
pooled for the arrays. cTNT-H9 cells were irradiated with 1 Gy X-rays and after 1 h, 6 h, 24 h and 7 d RNA 
samples were taken (n = 6) and analyzed for ACVR2B (A) and ACVR1B (B) expression via qRT-PCR. Values 
were normalized to 18sRNA.  
 
 
App. Fig. 14: Gene expression of ATM upon exposure to 1 Gy X-rays in the samples pooled for the arrays. 
cTNT-H9 cells were irradiated with 1 Gy X-rays and after 1 h, 6 h, 24 h and 7 d RNA samples were taken. In 3 
out of 6 experiments, ATM expression was investigated. 18sRNA was used for normalization. 
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App. Fig. 15: ATM expression in sham and 1 Gy irradiated cTNT-H9 cells seven days after exposure. One 
week after irradiation with 1 Gy X-rays, cTNT-H9 cells were fixed, permeabilized, blocked and stained against 
ATM. DNA was stained with Hoechst-33342 (blue). Scale bars: 20 µm. 
 
 
App. Fig. 16: p21 detection in sham and 1 Gy irradiated cTNT-H9 cells seven days after exposure. cTNT-
H9 cells were irradiated with 1 Gy X-rays and one week later, they were fixed, permeabilized, blocked and 
stained against p21 (red). DNA was stained with Hoechst-33342 (blue). Scale bars: 20 µm. 
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App. Fig. 17: Immunocytochemical detection of WNT11. cTNT-H9 cells (controls) were differentiated and at 
day 5 (A), 8 (B, C) and 15 (D) WNT11 protein was analyzed. Since expression of GFP was very low at day 5 (A, 
in the small cluster of cells on the left side) and also at day 8 in those clusters that did not start to beat yet (B, 
cells on the right and lower part of the picture), the green channel is not shown since the signal could not be 
distinguished from noise in the pictures. C, D) GFP-expressing clusters with WNT11-signal all over the nucleus 
and non-GFP-cells showing one big spot per cell near the nucleus. DNA was stained with Hoechst-33342. Scale 
bars: 10 µm. 
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App. Fig. 18: Positive controls for immunocytochemical staining of endothelial markers. A) HDMEC 
stained for CD31. B) HMVEC stained for vWF. DNA was stained with Hoechst33342. Scale bars: 10 µm. 
 
 
App. Fig. 19: Gene expression of MYH11 and AFP during cardiac differentiation of irradiated cTNT-H9 
cells. Expression of MYH11 (A) and AFP (B) in cardiac cultures derived from sham controls (black) or 0.1 Gy 
(gray), 1 Gy (green) or 2 Gy (red) irradiated cells was analyzed via qRT-PCR. Values were normalized to 
18sRNA and to day 15-control mRNA levels for each experiment. Student’s t-test was performed among 
experiments. * p < 0.05; blue symbols, gene expression level before irradiation; d, day. 
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App. Fig. 20: Beat rates of cardiac clusters derived from cTNT-H9 cells that were irradiated at day 5 or 8 
of cardiac differentiation. cTNT-H9 cells were differentiated according to Kadari et al., 2015 and irradiated at 
day 5 (gray boxes) or day 8 (white boxes) with 1 Gy X-rays. Controls (black boxes) were sham irradiated. 
Videos of at least 20 clusters were recorded at day 8, 10 (or 11), 15 (or 16), 22 and 29.  
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